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Optimizing the Collection and Use of Patient-Generated Health Data  
Meghan Reading 
 
 This dissertation aims to examine the collection and use of digital patient-generated 
health data (PGHD) in real-world settings, including existing barriers from the perspectives of 
patients and healthcare providers, and possible approaches to optimizing the process. In Chapter 
One, the potential of PGHD to improve health and wellness, particularly for individuals with 
chronic conditions, as well as known barriers to PGHD collection and use, are described. One 
chronic condition in particular, atrial fibrillation (AF), is then introduced as a use case for 
PGHD. Chapter Two contains an integrative review synthesizing findings from eleven studies 
reporting patients’ and providers’ needs when collecting and using PGHD, and identifying 
convergence and divergence between needs. Chapter Three contains a quantitative evaluation of 
sustained engagement, currently a major barrier to collection of PGHD, in a group of adults self-
monitoring AF, as well as predictors and moderators of engagement that come from an adapted 
version of the Unified Theory of Acceptance and Use of Technology (UTAUT). These 
individuals were previously enrolled in the randomized, controlled trial, the iPhone® Helping 
Evaluate Atrial Fibrillation Rhythm through Technology (iHEART). In Chapter Four, the 
adapted UTAUT model is explored in more detail through a qualitative investigation of sustained 
engagement with patients, healthcare providers, and research coordinators involved in the 
iHEART trial. Chapter Five summarizes the findings of this dissertation, including strengths and 
limitations, and elicits implications for the intersection of health policy and clinical practice, 
design, nursing, and future research from the findings.
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Chapter One: Introduction 
Chapter one outlines the organization and background of this dissertation. It begins by 
describing the public health burden of chronic disease in the United States and the potential for 
patient-generated health data (PGHD) to improve management of chronic disease. Barriers to 
collecting and using PGHD in practice are then discussed, with a focus on engagement with 
mobile health (mHealth) technologies used to collect PGHD. Subsequently, one chronic disease 
in particular, atrial fibrillation (AF), is highlighted as a use case for PGHD. Then, the theoretical 
model utilized in this research will be described. Finally, the plan for three separate manuscripts 
and their respective aims that comprise this dissertation will be summarized. The first manuscript 
(Chapter Two) was published in the Journal of the American Medical Informatics Association. 
The second manuscript (Chapter Three) is planned for submission to the Journal of 
Cardiovascular Nursing. The third manuscript (Chapter Four) is currently under review at 
Applied Clinical Informatics. Together these papers report on PGHD collection and use in real-
world settings and reveal possible design options for optimizing the process, especially with 
regards to sustained patient engagement. 
Chronic Disease Burden in the United States 
Chronic diseases are the most common and costly of all health problems. There are 150 
million individuals living with at least one chronic disease in the United States (U.S.), and more 
than 100 million have more than one (Buttorff, 2017). These individuals account for 90% of all 
healthcare spending in the U.S. (Buttorff, 2017; CDC, 2016). An estimated seven out of ten 
deaths are caused by chronic disease (CDC, 2016). Furthermore, the number of adults with 
multiple chronic diseases is increasing, and the more chronic diseases an individual has, the more 
frequent and costly their care is (Buttorff, 2017). Adults 65 years of age and older are 
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disproportionally affected by chronic diseases with prevalence rates greater than 80% in this 
population. In addition, chronic diseases are more common among non-Hispanic whites (63% 
prevalence) and non-Hispanic blacks (58% prevalence) than among Hispanics and other 
race/ethnic groups (Buttorff, 2017). However metabolic syndrome, a cluster of conditions that 
increases the risk of chronic conditions including heart disease, stroke, and diabetes, is higher in 
Hispanics (Heiss et al., 2014).  
Chronic diseases may last for years or even decades of a person’s life. An individual’s 
daily decisions regarding diet, physical activity, medication adherence, and other behaviors all 
impact the long-term trajectory of a chronic disease (CDC, 2016; Milani, Bober, & Lavie, 2016). 
Self-monitoring is a critical component of effective chronic disease self-management because it 
allows changes in health status to be addressed in a timely manner, thereby reducing the risk of 
hospitalization, complications, and in some cases, death (Lasorsa et al., 2016; Milani et al., 
2016). In fact, currently many evidence-based guidelines for specific chronic diseases recognize 
self-monitoring as an important component of disease management (CDC, 2016; January et al., 
2014; Lasorsa et al., 2016). Effective self-monitoring requires real-time data on health status and 
behaviors, and ongoing health professional facilitation of the patient as they self-monitor (Milani 
et al., 2016; Shaw, Bonnet, Modarai, George, & Shahsahebi, 2015).  
However the healthcare structure in the U.S. only affords individuals with chronic 
diseases periodic visits with healthcare providers that leave little to no time for self-monitoring 
data to be reviewed (Gee, Greenwood, Paterniti, Ward, & Miller, 2015; Milani et al., 2016). 
Additional barriers to self-monitoring are limited health literacy and inadequate communication 
with providers (Bauer, Thielke, Katon, Unutzer, & Arean, 2014). There is a clear need for more 
frequent and comprehensive support of individuals living with chronic diseases that addresses 
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these modifiable barriers (e.g., health literacy, communication) (Bauer et al., 2014). Furthermore, 
there is a need for this care to be personalized due to the complex combinations of behavioral, 
environmental, and biological factors that influence the trajectory of chronic diseases (Lavallee 
et al., 2016). 
Patient-Generated Health Data (PGHD) 
The Promise of Patient-Generated Health Data (PGHD) 
Mobile health (mHealth) technologies, which capitalize on the popularity, affordability, 
and sophistication of smartphones and other mobile devices, are increasingly being recognized as 
a tool that may improve management of chronic disease (Ali, Chew, & Yap, 2016; Bonoto et al., 
2017). In the U.S. 89% of adults report owning a smartphone and the average user checked their 
smartphone 46 times per day in 2015 (Deloitte, 2015; Pew, 2017). In addition, smartphone use is 
reportedly similar across socioeconomic groups and geographic locations (Garabedian, Ross-
Degnan, & Wharam, 2015). Thus, there is potential for individuals from diverse backgrounds 
who may be medically underserved to benefit from mHealth technologies. Examples of mHealth 
include health applications (apps), wearable devices, and other connected health monitors. 
mHealth can be used to push health education, notifications, and data to patients 
(Bhavnani, Narula, & Sengupta, 2016). Individuals can also use mHealth to digitally collect 
health data about themself, creating what is known as patient-generated health data (PGHD). 
This is longitudinal, high frequency health-related data recorded by a patient or caregiver outside 
of clinical settings to address a health concern (Wood, Bennett, & Basch, 2015). Patient-reported 
outcomes (PROs) are a structured form of PGHD (Howie, Hirsch, Locklear, & Abernethy, 
2014). Self-monitoring and the generation of PGHD is not new but previously was limited to 
paper-based documentation shared with providers at discrete time points. The increasing 
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availability of smartphones and mobile devices in recent years has allowed for self-monitoring 
data to be continuously recorded, stored, and transmitted to healthcare providers digitally.  
Digital PGHD has the potential to improve information exchange between patients and 
providers, increase patient satisfaction, and enhance the provider’s overall understanding of the 
patient (Arsoniadis et al., 2015; Lavallee et al., 2016). Moreover, patients report improved 
understanding of their disease and factors that contribute to it because they are able to collect and 
visualize their data more efficiently with digital technologies (A. E. Chung & Basch, 2015; 
Howie et al., 2014). Though still in its nascent stages, there is already some evidence of PGHD 
improving health outcomes. A recent systematic review of individuals with diabetes using 
mHealth technology to self-manage, which included collecting and using digital PGHD, found a 
significant improvement in hemoglobin A1c, a marker of diabetes control (Greenwood, Gee, 
Fatkin, & Peeples, 2017). 
In recognition of the value of digital PGHD, a series of recent policy efforts are 
prioritizing the exchange of PGHD between patients and providers by way of the electronic 
health record (EHR). In 2015, the Office of the National Coordinator of Health Information 
Technology (ONC) began a ten-year project to develop a patient- and provider-centered policy 
framework for sharing PGHD (HealthIT.gov, 2016). Patients may soon be able to view, 
download, and transmit their health data to the EHR as part of Stage 3 of the Health Information 
Technology Certification Criteria for Meaningful Use (MU3) and the Medicare Access and 
Children's Health Insurance Program (CHIP) Reauthorization Act of 2015 (MACRA) 
(HealthIT.gov, 2015). Additionally, the Precision Medicine Initiative has prioritized funding 
projects that integrate new forms of health data, including PGHD, into the EHR (NIH, 2018). 
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Finally, in 2018 the Centers for Medicare and Medicaid Services (CMS) initiated changes to 
healthcare provider reimbursement that incentivized review of PGHD (CMS, 2017a). 
Challenges to Collecting and Using PGHD  
Despite aligning efforts to support the collection and use of PGHD, barriers to 
implementation in clinical practice remain. Differences in methods of measuring and collecting 
data between patients generate concerns about data quality (Lavallee et al., 2016). Compliance 
with privacy and confidentiality regulations of patient data (e.g., Health Insurance Portability and 
Accountability Act, or HIPAA) is variable between mHealth apps and devices, and developers 
may not fully understand or comply with these regulations (A. E. Chung & Basch, 2015). 
Current clinical workflows are not designed to accommodate PGHD, and questions of 
reimbursement, time, staffing, roles, and scope of practice have yet to be fully answered (Howie 
et al., 2014). Furthermore, few institutions have successfully integrated PGHD into the EHR 
(Kumar, Goren, Stark, Wall, & Longhurst, 2016; Lobelo et al., 2016). While a lack of EHR 
integration limits the utility of PGHD in clinical settings, efforts to advance EHR integration are 
complicated by interoperability requirements and concerns about data quality and security (A. E. 
Chung & Basch, 2015; Kumar et al., 2016). 
One major problem affecting the utility of PGHD is high rates of abandonment among 
patients who are self-monitoring (ONC, 2016). Studies measuring self-monitoring over an 
extended period of time show that many patients who are using mHealth to self-monitor 
discontinue use within three to six months of initiation, suggesting that patients are not engaged 
in the process for a sustained period of time (Coa & Patrick, 2016; Glasgow et al., 2011; Mattila 
et al., 2013). The length of time that mHealth users must sustain engagement with the technology 
is pre-specified depending on the ultimate goal of use (K. Anderson & Emmerton, 2015; Goyal 
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et al., 2016). For individuals living with one or more chronic diseases, the potential health 
benefits of self-monitoring are unlikely to be immediate or obvious, but rather manifested in 
long-term successes (e.g., improved overall wellness and reduced risk of complications) 
(Chouvarda, Goulis, Lambrinoudaki, & Maglaveras, 2015; Milani et al., 2016). 
Therefore longitudinal data collection for individuals with chronic diseases is often more 
valuable than brief, discrete periods of monitoring, because trends and correlations between 
factors that may affect chronic diseases over time can be uncovered (Kevin Anderson, Burford, 
& Emmerton, 2016). However, longitudinal data collection is only possible if patients remain 
engaged with self-monitoring for a sustained period of time. Furthermore, part of the promise of 
PGHD is that both the provider and the patient collaboratively learn from their data about how 
best to manage the disease. Therefore patient engagement with self-monitoring is a necessary 
precursor for patients to be engaged in their care overall (Gee et al., 2015; Milani et al., 2016). 
Finally, sustained engagement is arguably the most urgent of barriers to PGHD being utilized in 
clinical practice because all other barriers are distal to sustained engagement; they rest on the 
assumption that PGHD is being collected in the first place (ONC, 2016).  
Little is known about personalized approaches to improve sustained engagement. Much 
of the existing literature on user engagement focuses on strategies to improve initial uptake 
rather than sustained engagement (Ford et al., 2015; Lasorsa et al., 2016). The few studies that 
have examined sustained engagement have focused almost exclusively on mHealth features, such 
as gamification and incentives, rather than intrinsic qualities of the user (King et al., 2013; 
Shimada, Allison, Rosen, Feng, & Houston, 2016). These approaches have largely failed to 
sustain user engagement. A promising alternative approach is focusing on individual user 
characteristics that may predict sustained engagement. Previous studies have demonstrated that 
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individual characteristics, such as age and disease status, affect sustained engagement with 
mHealth (Mattila et al., 2013; Muessig, Baltierra, Pike, LeGrand, & Hightow-Weidman, 2014; 
Pavliscsak et al., 2016). This is supported by focus group findings suggesting that control over 
mHealth features, context provided with health data, and data shared with healthcare providers 
would improve sustained engagement (Horvath, Alemu, Danh, Baker, & Carrico, 2016; 
Miyamoto, Henderson, Young, Pande, & Han, 2016). These reported factors demonstrate the 
need for mHealth technologies to be personalized. 
Because systems to collect and display PGHD are still evolving, now is the optimal time 
to incorporate patient and provider feedback into iterative design processes (Peres, Pham, & 
Phillips, 2013). Nurses in particular have a major opportunity in clinical and research settings to 
help develop PGHD-integration systems and incorporate both the patient’s voice and provider’s 
perspective into them (Hull, 2015). Two core areas of nursing informatics work are: (1) the 
development of approaches for presenting and retrieving information, and (2) leading the 
development, design, and implementation of health information technologies (AMIA, 2009). As 
patient advocates, PGHD can be a tool for patient empowerment, and will be increasingly 
importantly to all nurses. 
AF as a Use Case for PGHD 
The studies in Chapters Three and Four focus on one specific chronic condition, atrial 
fibrillation (AF), as a use case for PGHD. AF is the most common cardiac arrhythmia 
encountered in clinical practice, affecting between 2.7 and 6.1 million people in the U.S. (CDC, 
2015). Prevalence estimates vary enormously due to difficulty detecting AF in “real world” 
settings. Current approaches for detecting and managing AF typically include brief (24-72 hours) 
electrocardiogram (ECG) monitoring and prescheduled health visits (Turakhia & Kaiser, 2016). 
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These approaches are inadequate given the sporadic, unpredictable nature of the arrhythmia, so 
that AF often goes undetected and thus untreated (Olgun Kucuk, Kucuk, Yalcin, & Isilak, 2015; 
Turakhia & Kaiser, 2016). Failure to detect and treat AF can lead to heart failure, myocardial 
infarction, stroke, and death (Olgun Kucuk et al., 2015). As such, AF represents a major public 
health problem, accounting for more than 750,000 hospitalizations, 130,000 deaths, and $6 
billion in costs each year (CDC, 2015). Innovative methods that integrate real world approaches 
and utilize advances in technology for monitoring and detecting AF in real time are needed to 
facilitate timely treatment and prevent adverse cardiovascular outcomes, hospitalization, and 
death.  
Mobile health technology (mHealth) represents a major opportunity to assist AF patients 
with self-management. Electrocardiogram (ECG) mHealth technology, such as the AliveCor™ 
device, allows individuals with AF to easily record and transmit an ECG to their healthcare 
provider for review using a device that works with smartphones. Studies have demonstrated that 
this technology can accurately detect and identify arrhythmias such as AF (McManus et al., 
2016; Steinhubl et al., 2016). The SEARCH-AF study found that use of this technology in 
community settings was both cost-effective and feasible (Lowres et al., 2014). This indicates that 
the technology is mature enough for real world integration in the community. ECG mHealth 
technology has the potential to assist patients with AF through timely detection of AF episodes. 
Timely detection is needed to restore normal sinus rhythm earlier, improve disease management 
through medication and lifestyle adjustments, and reduce health risks of AF such as 
hospitalization, stroke, or death (Olgun Kucuk et al., 2015; Steinhubl et al., 2016). For these 
reasons, timely detection may also facilitate improved quality of life and reduced public health 
burden of AF (Olgun Kucuk et al., 2015; Steinhubl et al., 2016). Furthermore, individuals with 
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AF perceive a need for ECG mHealth technology. In a recent survey, most individuals living 
with a cardiac condition, such as AF, reported a need for technology-based support to increase 
health knowledge, decrease travel and accessibility restraints, and better utilize peer support 
(Disler RT, 2015). 
Sustained engagement with self-monitoring via ECG mHealth technology is a critical 
issue for individuals with AF. The goal of ECG mHealth technology is to better detect and treat 
AF episodes in a timelier manner (Steinhubl et al., 2016; Turakhia & Kaiser, 2016). However AF 
is spontaneous, unpredictable, and most likely to recur in the first six months after an 
intervention to restore normal sinus rhythm (Heidenreich et al., 2016; January et al., 2014). 
Therefore, users of ECG mHealth technology must sustain engagement for at least six months 
after restoration of normal sinus rhythm for AF to be detected and treated in a timely manner 
(Steinhubl et al., 2016). Furthermore, individuals living with AF are unique and differ from the 
general population (Heidenreich et al., 2016). There is a need to understand the unique 
characteristics of individuals with AF to improve understanding on sustained engagement in this 
population. Understanding individual user characteristics that influence sustained engagement 
will facilitate the development of personalized approaches to mHealth-based self-management.  
The iHEART Trial 
The iPhone® Helping Evaluate Atrial Fibrillation Rhythm through Technology trial 
(iHEART) is a single-center, randomized, controlled trial (RCT) supported by the National 
Institute of Nursing Research (NINR; R01NR014853). It is a five-year trial that began in 2014 
(Hickey et al., 2016). Planned enrollment in the iHEART trial is 300 individuals (to date all 300 
have been enrolled) with a history of AF who have undergone an intervention to restore normal 
sinus rhythm in the last 30 days. Inclusion criteria in the original iHEART trial are English or 
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Spanish speaking, age 18 or older, and have a history of AF in the last 30 days for which 
treatment successfully restored normal sinus rhythm. Exclusion criteria are documented 
permanent or chronic AF, and patient found to be unstable or have other arrhythmias on day of 
enrollment. 
Participants are randomized 1:1 to receive usual cardiac care or usual care plus the 
iHEART intervention for six months. Participants randomized to the iHEART intervention 
receive an AliveCor™ Heart Monitor (Figure 1.1) and iPhone® (if they do not own one) 
preloaded with the accompanying Kardia® application. They are asked to transmit ECGs at least 
once daily using the technology for six months. Through a separate application, intervention arm 
participants also receive personalized behavioral altering motivational (BAM) text messages 
three times per week targeting their individual cardiac risk factors, but do not need to reply to 
text messages.  
 
Figure 1.1. AliveCor mobile ECG monitor and smartphone application 
Data from the patient’s EHR and validated surveys is collected for six months. Validated 
surveys inquire about quality of life, AF knowledge, symptoms, and experience using ECG 
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mHealth technology. Actual technology use is documented in the form of time-stamped, dated 
ECGs recorded using the AliveCor™ device, and stored in a HIPPA-compliant, encrypted, and 
secure AliveCor™ database. The primary endpoint of the iHEART trial is detection of AF 
recurrence. Secondary endpoints are treatment changes resulting from AF detection, changes in 
survey scores, and improvement in clinical cardiac measurements (i.e., weight, blood pressure) 
and AF knowledge from baseline to six months. As the iHEART trial nears completion, there is a 
need to determine the real-world utility of PGHD collected with the AliveCor™ device and 
integrated in everyday clinical practice to improve outcomes. 
Institutional Review Board Approval 
 This study obtained approval from the Institutional Review Board at Columbia 
University Medical Center (CUMC, Protocol AAAO2555).  
Theoretical Framework 
Unified Theory of Acceptance and Use of Technology 
The studies in Chapters Three and Four were guided by an adapted version of the Unified 



































































































Venkatesh et al. first developed the UTAUT model in 2003 by combining elements from 
eight models and theories of behavior change and technology acceptance, including the theory of 
reasoned action, the technology acceptance model, and the theory of planned behavior. 
Validation of the model demonstrated that it explains variation in technology acceptance and use 
better than its component models (R2= 0.69 compared to 0.17-0.53). The UTAUT model has 
been used extensively to understand technology acceptance and use in non-healthcare settings, 
such as education, banking, and 3G mobile communication (Attuquayefio & Addo, 2014). The 
model has begun to appear in healthcare research settings in recent years. One study has used 
UTAUT in ECG monitoring in a community-dwelling cardiac population (Lin, Wong, & Tseng, 
2016). However this study measured technology acceptance but not sustained engagement. 
Recently, UTAUT was adapted to explain sustained engagement with mHealth 
technology for lung transplant recipients after surgery (Jiang, Sereika, Dabbs, Handler, & 
Schlenk, 2016). The adapted UTAUT model validated by Jiang et al. (2016) will be used in this 
dissertation because it predicts sustained engagement (Figure 1.2). It includes three predictors of 
sustained engagement: (1) perceived usefulness, (2) perceived ease of use, and (3) facilitating 
conditions. It also includes three moderating factors: (1) age, (2) gender, and (3) experience with 
technology. Jiang et al. (2016) included intention to use technology as a predictor of sustained 
engagement. This predictor was omitted from the adapted UTAUT model that is used in this 
dissertation because data on actual technology use is available from the parent iHEART study. 
The facilitating conditions predictor can be operationalized differently depending on the 
population being studied (Attuquayefio & Addo, 2014; Venkatesh, Morris, Davis, & Davis, 
2003). Based on the facilitating conditions included by Jiang et al. (2016) and the variables 
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available from the parent iHEART study, the facilitating conditions used in this dissertation are: 
(1) severity of AF symptoms, (2) frequency of AF episodes, and (3) AF knowledge. 
Dissertation Aims and Organization 
This dissertation is comprised of three manuscripts that comprise the next three chapters. 
The manuscript title and aims of each chapter are presented in Table 1.1. 
Table 1.1: Dissertation Chapters, Manuscript Titles, and Aims Addressed 
Chapter Title Aim  
2 Converging and Diverging Needs 
described by Patients and Providers 
that collect and use Patient-Generated 
Health Data: An Integrative Review 
1. Identify (a) needs of both healthcare
providers and patients concerning the 
collection and use of digital PGHD and 
(b) identify areas of convergence and 
divergence between them. 
3 A Theory-Driven Exploration of 
Factors Associated with Sustained 
ECG Self-Monitoring in a Post-
Intervention Atrial Fibrillation 
Population 
2. Evaluate engagement with ECG
mHealth technology among adults with 
AF over one year, as well as predictors 
and moderators of sustained engagement. 
4 Factors Influencing Sustained 
Engagement with ECG Self-
Monitoring: Perspectives from 
Patients and Healthcare Providers 
3. Explore (a) individual patient
differences in sustained engagement 
among adults with AF who are collecting 
and using PGHD, and (b) potential 
approaches for improving sustained 
engagement. 
Chapter Two is an integrative review that synthesizes the needs of patients and healthcare 
providers when collecting and using PGHD. Specifically, this reviewed aimed to identify 
convergent and divergent patient and provider needs in using PGHD in real-world settings (Aim 
1). This provides a baseline understanding of facilitators and barriers to PGHD collection and 
use, and set the stage for understanding one major problem in particular, sustained engagement. 
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In the study described in Chapter Three, factors from the adapted UTAUT model were 
quantitatively tested to determine their relationship to sustained engagement in a population of 
patients collecting and using PGHD for AF management. This study aimed to evaluate 
engagement with ECG mHealth technology among adults with AF over one year, as well as 
predictors and moderators of sustained engagement (Aim 2). It is a secondary data analysis of 
AliveCor™ usage data and surveys from 132 adults with AF who participated in the intervention 
arm of the iHEART randomized controlled trial. Hierarchical generalized linear models (HGLM) 
were used to evaluate engagement, as well as predictors and moderators of engagement that 
came from the adapted UTAUT model. 
 In the study described in Chapter Four, factors in the adapted UTAUT model were 
further explored, as were additional factors related to sustained engagement that were not 
included in the adapted UTAUT model. Qualitative focus groups with providers and patients 
utilizing PGHD for management of AF were conducted to substantiate the quantitative findings 
with further insight on factors that may contribute to sustained engagement with ECG mHealth 
technology in this population, but that may not have been measured or fully understood in the 
quantitative analysis. Specifically, the focus group guides aimed to elicit: (1) individual patient 
differences in sustained engagement among adults with AF who are collecting and using PGHD, 
and (2) potential approaches for improving sustained engagement (Aim 3). Qualitative data was 
analyzed using directed content analysis, which allowed the adapted UTAUT model to guide 
exploration of concepts that emerge from the data. 
Together these papers report on multiple aspects of motivation and barriers to the 
collection and use of PGHD by both patients and providers, and identify potential approaches for 
optimizing the process. 
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Conclusion 
The research aims to find ways to optimize the process of PGHD collection and use for 
both patients and providers by identifying their common needs and potential approaches to meet 
these needs. A review of the needs of patients and providers who are collecting and using PGHD 
is presented in Chapter Two. Currently, a major barrier to PGHD collection is patient sustained 
engagement with self-monitoring. Therefore, sustained engagement is studied in detail in the 
studies described in Chapters Three and Four. 
The implications of understanding factors associated with sustained engagement are the 
potential to increase use of point-of-care self-monitoring devices, improve self-management of 
AF, and optimize the positive health outcomes resulting from use of mHealth technology. The 
findings of this research suggest design options for systems that collect and display PGHD in 
general (Chapter Two) and specifically such that patient sustained engagement is optimized 
(Chapters Three and Four). Given the continued popularity and availability of mHealth 
technologies among patients and recent policy changes that incentivize healthcare providers to 
review PGHD (CMS, 2017a), the findings of this research will continue to be disseminated to 
peer-reviewed journals in a timely manner. 
Additionally, the findings will be presented at conferences in biomedical informatics, 
cardiology, and nursing, including the American Medical Informatics Association (AMIA) and 
American Heart Association (AHA) annual scientific sessions. Preliminary findings on iHEART 
trial participants’ AliveCor™ usage patterns and the influence of AliveCor™ use on cardiac 
endpoints have been presented at the AHA 2017 Scientific Sessions, Eastern Nursing Research 
Society 2018 Scientific Sessions, and Heart Rhythm Society 2018 Scientific Sessions, and an 
abstract has been published in the journal Circulation (M. Reading, Biviano, Mitrani, & Hickey, 
17 
2017). In sum, findings from this research provide insights into real-world approaches for 
improved management of chronic conditions such as AF, as well as potential strategies to 
optimize user engagement with mHealth applications over an extended period of time. 
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Chapter Two: Converging and Diverging Needs between Patients and Providers who are 
Collecting and Using Patient-Generated Health Data: An Integrative Review
The study in Chapter Two addresses the first aim of the dissertation in an integrative 
review that examines convergent and divergent areas of need for collecting and using patient-
generated health data (PGHD) identified by patients and healthcare providers. The final 
manuscript was accepted for publication in the Journal of the American Medical Informatics 
Association (JAMIA) on January 29, 2018 (doi: 10.1093/jamia/ocy006). The published version 
is included in Appendix A. 
Abstract 
Objective: This integrative review identifies convergent and divergent areas of need for 
collecting and using patient-generated health data (PGHD) identified by patients and providers 
(i.e. physicians, nurses, advanced practice nurses, physician assistants, and dietitians). 
Materials and Methods: A systematic search of nine scholarly databases targeted peer-reviewed 
studies published after 2010 that reported patients’ and/or providers’ needs for incorporating 
PGHD in clinical care. The studies were assessed for quality and bias with the Mixed-Methods 
Appraisal Tool. The results section of each article was coded to themes inductively developed to 
categorize patient and provider needs. Distinct claims were extracted and areas of convergence 
and divergence identified. 
Results: Eleven studies met inclusion criteria. All had moderate to low risk of bias. Three themes 
(clinical, logistic, and technological needs) and 13 subthemes emerged. Forty-eight claims were 
extracted. Four were divergent and twenty were convergent. The remainder was discussed by 
only patients or only providers. 
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Discussion: In examining patients’ and providers’ needs concurrently, the findings demonstrate 
interplay between patients’ and providers’ needs. Patients need feedback and reassurance, and 
providers need to manage the flow of PGHD in their clinical practice. Convergent needs may 
serve as the basis for an initial set of requirement specifications for information systems that 
satisfy both users. Divergent needs highlight the necessity of incorporating transparency and 
strategies for patients and providers to communicate about the PGHD process. 
Conclusion: As momentum gains for integrating PGHD into clinical care, this analysis of 
primary source data is critical to understanding the needs of the two groups directly involved in 
collection and use of PGHD. 
Background and Significance 
As of January 1, 2018 the Centers for Medicare and Medicaid Services (CMS) initiated 
policy changes that will incentivize and reimburse healthcare providers for reviewing and 
interpreting patient-generated health data (PGHD), which is expected to accelerate adoption and 
use of these data in clinical practice (CMS, 2017a, 2017b). PGHD is a term to describe “health-
related data… created, recorded, gathered, or inferred by or from patients or their designees (e.g., 
care partners or those who assist them) to help address a health concern” (Wood et al., 2015). 
Key features of PGHD are: (a) the patient, not the healthcare provider, captures the data, (b) the 
data are obtained outside of clinical settings, and (c) the data are both longitudinal and capable of 
being collected at high-frequency intervals. Patient-reported outcomes (PROs) are considered a 
controlled form of PGHD, typically consisting of structured data elements captured at discrete 
intervals (Howie et al., 2014). 
Increasingly PGHD are collected and stored digitally via ubiquitous smartphone 
applications (apps), connected devices, and cloud-based platforms (C. F. Chung et al., 2016; 
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Howie et al., 2014; Lavallee et al., 2016; Shaw et al., 2015). PGHD produces not only 
information and knowledge to support clinical decision-making for individual health care 
providers, but also a context for those decisions (A. E. Chung & Basch, 2015; Shaw et al., 2015). 
For instance, knowledge of circumstances external to a patient’s clinical situation may call for 
adjustments to therapeutic decisions made by any provider within a health care team (e.g. 
physicians, nurses, advanced practice nurses, physician assistants, and dietitians). Current 
evidence on the clinical benefit of PGHD is sparse but emerging as technology and policy 
provide the means to incorporate it into clinical practice (Greenwood et al., 2017; Lai, Hsueh, 
Choi, & Austin, 2017; Lv et al., 2017). 
On a policy level, digital PGHD may contribute to healthcare quality by augmenting the 
type, amount, and detail of health information exchanged between patients and providers (Bauer 
et al., 2014; Chouvarda et al., 2015). Healthcare costs associated with unnecessary office visits 
and hospitalizations may decrease when patients share PGHD by allowing the provider to 
proactively manage illnesses and prevent complications (Howie et al., 2014). Patients with 
previous barriers to healthcare for cost- or location-related reasons may now exchange health 
information more easily and affordably with providers because mobile device ownership is 
prevalent across diverse populations (Bauer et al., 2014; Howie et al., 2014; Lavallee et al., 
2016). 
The U.S. Office of the National Coordinator for Health Information Technology (ONC) 
has identified the value and existing challenges for patients and providers regarding PHGD, and 
called for evidence-based strategies to facilitate its adoption and use (ONC, January 2018b). An 
understanding of PGHD from the patient and provider perspectives is needed to align concurrent 
policy efforts that aim to incorporate PGHD into clinical care, such as the Medicare and 
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Medicaid Electronic Health Record Incentive Programs Stage 3 and Modifications to Meaningful 
Use (MU3), and the Medicare Access and Children’s Health Insurance Program Reauthorization 
Act of 2015 (MACRA) (ONC, January 2018b). 
Objective 
A synthesis of the evidence regarding patient and provider needs for information systems 
that incorporate PHGD can inform their optimal development (Lavallee et al., 2016; Woods, 
Evans, & Frisbee, 2016). To our knowledge there is no review that examines empirical evidence 
on the needs of the two primary users of PGHD. Therefore, the aims of this integrative review 
are to (1) summarize needs of both healthcare providers and patients concerning the collection 
and use of digital PGHD and (2) identify areas of convergence and divergence between them. 
The review follows procedures and recommendations detailed by Whittemore and Knafl (2005). 
Methods 
Information Sources and Search strategy 
Nine scholarly databases (Pubmed, Scopus, Applied Science, Medline, PsycINFO, 
Science Direct, CINAHL, Cochrane and ACM Digital Library) were searched in November 2016 
using the terms: “Patient generated health data,” “Patient generated data,” “Patient reported 
outcome(s) [AND] digital,” “Patient reported data [AND] digital,” and “Self-monitoring data.” 
Search terms were determined in consultation with a biomedical librarian and two experts 
engaged in research involving PGHD, and iteratively by examining key words in retrieved 
publications. Patient reported outcomes (PROs) are a type of patient-generated health data, 
which in some cases are recorded digitally (Forsberg et al., 2015; Howie et al., 2014). Therefore 
PROs were included in the search terms for thoroughness. No filters or additional search criteria 
were applied. Scopus was searched for grey literature using the same terms. An inspection of 
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reference lists from retrieved articles identified any relevant publications not obtained through 
the database search. 
Eligibility Criteria 
Publications were evaluated against the following criteria: (a) documented patients’ or 
providers’ needs, (b) PGHD was used in a “real world” rather than study setting, (c) addressed 
any type of digital PGHD collected for any health-related purpose (e.g. chronic disease 
management, post-operative monitoring, etc.), and (d) any study design (qualitative, quantitative, 
or mixed-methods). Exclusion criteria were: (a) published prior to 2011, (b) not a peer-reviewed 
article, (c) non-digital PGHD, (d) PGHD not used in “real world setting” and clinical workflow 
and (e) not reporting patients’ and/or providers’ perspectives. We define workflow as “a modular 
sequence of tasks, with a distinct beginning and end, performed for the specific purpose of 
delivering clinical care” (HealthIT.gov). Studies with samples of only patients or only providers 
were included provided they met other inclusion criteria. 
The specification of “digital” data was thought to automatically exclude older studies, so 
publication year search filters were not initially applied. However this approach retrieved several 
studies published between 1980 and 2010 reporting on now obsolete technology. The publication 
date criterion was added in acknowledgement of the rapid development of patient- and provider-
facing health information technology within the past five years. Unlike non-electronic (e.g., 
verbal or written) information generated by patients, digital PGHD can be collected with greater 
frequency and detail and computationally summarized. These features present unique 
opportunities and challenges, which are the focus of this review. 
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Data Screening, Extraction, and Synthesis 
Two reviewers used Covidence, a Cochrane technology platform, to select eligible 
studies from the pool of retrieved records ("Covidence systematic review software," 2016). 
Covidence automatically removes most duplicate records. The reviewers removed any missed 
duplicate records. Then the reviewers screened titles and abstracts against the inclusion/ 
exclusion criteria. Full texts of the records included were rescreened using the same criteria. Any 
discrepancies between the reviewers were discussed and resolved. 
Methodological Quality Assessment of Studies 
Quality was evaluated with the Mixed Methods Appraisal Tool (MMAT) (Pluye, 
Gagnon, Griffiths, & Johnson-Lafleur, 2009), which is specifically designed for concomitantly 
appraising quantitative, qualitative, and mixed-methods research. MMAT was chosen for its 
ability to produce comparable scores across study designs (Pace et al., 2012; Pluye et al., 2009), 
with highly reliable inter-class correlations (ICC) ranging from 0.84 to 0.94 (Johnston et al., 
2016; Mey et al., 2016; Tretteteig, Vatne, & Rokstad, 2016). 
The MMAT consists of two initial screening questions and subsequent question sets that 
are specific to the study design (quantitative; qualitative; or mixed-methods). The screening 
questions identify studies for which further appraisal may not be feasible or appropriate (e.g. no 
clear research question.) Studies failing either or both screening questions do not proceed to 
domain-specific appraisal. Domain-specific questions number four for qualitative studies and 
four questions for each of the three quantitative study designs (randomized controlled, non-
randomized, or descriptive). Mixed-methods studies are evaluated using both the qualitative and 
appropriate quantitative study questions. There are three additional questions specific to mixed-
methods studies. The quality appraisal score is determined by dividing n criteria met by N 
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criteria in each applicable domain. Scores are typically converted to percentages for comparison 
across studies (Pace et al., 2012; Pluye et al., 2009). Following this protocol, two reviewers 
(M.R., J.M.) independently appraised and calculated scores for each study. As in the earlier 
stage, discrepancies between the reviewers were discussed and resolved. 
Data Extraction and Qualitative Synthesis 
The goals of data analysis in integrative reviews are first, to provide an unbiased and 
complete interpretation of primary source data, and second, to critically synthesize this data 
(Whittemore & Knafl, 2005). The primary author (M.R.) reviewed and extracted relevant 
characteristics from each study including: sample characteristics, setting, context, PGHD 
collected, HIT used, study design, data collection methods, data analysis methods, and study 
findings. 
Both reviewers (M.R., J.M.) analyzed the quantitative and qualitative data using a general 
inductive approach to develop a unified response to the objectives of the integrative review. The 
steps include: (1) data reduction, (2) data display, (3) data comparison, (4) conclusion drawing 
and verification (Whittemore & Knafl, 2005). During data reduction, text containing the 
qualitative and/or quantitative findings was excerpted from each article and combined into a 
single corpus. The primary author (M.R.) coded this text using a general inductive approach in 
which codes were developed, consolidated if warranted, and then organized into a hierarchy. 
From this process, a set of thematic axes emerged. The second reviewer (J.M.) independently 
coded 50% of the records using this preliminary schema with the freedom to identify new or 
alternative codes. Alternative codes were discussed until consensus was reached on a final 
coding schema, which was used for inter-rater reliability calculation. To further distill the 
findings for subsequent comparison, both reviewers revisited the coded text to identify distinct 
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expressions of a need related to PGHD, which they extracted in the form of declarative 
statements, or “claims.” NVivo Version 11.4.1 (QSR International, Inc., Burlington, MA) was 
used to code the data and calculate inter-rater reliability. 
Second, a table of findings was created to display the data and visualize claims according 
to the coding theme/sub-theme and patient/provider perspectives on each claim. Third, the claims 
were reviewed and discussed to determine the presence of patterns and relationships. The 
perspectives of individual claims were reviewed and discussed to evaluate if the viewpoints 
expressed were convergent, divergent, or identified by only patients or only providers. Finally, 
each declarative claim was verified with primary source(s) to ensure accuracy. Specifically, the 
primary author (M.R.) mapped the claims back to the theme they were originally coded under, 
and both reviewers participated in reordering or consolidating claims if warranted. 
Results 
Search Results 
A total of 996 records were retrieved from nine databases (Figure 2.1). Removal of 
duplicate records (n=274) left 722 articles for the title/abstract screening. During title/abstract 
screening, 644 records were excluded for: publication date prior to 2011 (n=356), not peer-
reviewed (n=122), not digital PGHD (n=86), and not about integrating PGHD into clinical 
workflow (n=80). A full text screening of 78 remaining records excluded 67 for: reporting 
neither patient nor provider perspective (n=37); not digital PGHD (n=17); and not about 
integrating PGHD into the clinical workflow (n=13). A total of 11 records were accepted for 
review (Cheng, Hayes, Hirano, Nagel, & Baker, 2015; C. F. Chung et al., 2016; Cohen et al., 
2016; Hartzler, Izard, Dalkin, Mikles, & Gore, 2016; Hochstenbach, Zwakhalen, Courtens, van 
Kleef, & de Witte, 2016; Huba & Zhang, 2012; Kummerow Broman et al., 2015; Lind, Carlgren, 
& Karlsson, 2016; Nundy, Lu, Hogan, Mishra, & Peek, 2014; Sanger et al., 2016; Thompson & 
26 
Valdez, 2015). The provider perspectives covered in these records included physicians, nurses, 
advanced practice nurses, physician assistants, and dietitians. 
Figure 2.1. Flow Diagram of Study Selection Process 
27 
Risk of Bias 
Quality appraisal results of the four qualitative and seven mixed-methods studies are 
























































































































































































































































































































































































































































































































































































































































































































































































































































































Qualitative studies received five to six of six possible points, and the mixed-methods studies 
received eight to eleven of thirteen possible points. When converted to percentages, studies 
scored from 62% to 100%. Studies lost points in the qualitative domain for claiming a specific 
method (e.g., grounded theory) but describing data analysis inconsistent with that method, or for 
failing to acknowledge, or “bracket,” their interaction with study participants as a potential 
source of bias. Studies lost points in the quantitative domain for sampling strategies that 
introduced bias, or surveys not psychometrically validated. 
Characteristics of Included Studies 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Six studies included both patients and provider participants (Cheng et al., 2015; C. F. Chung et 
al., 2016; Hartzler et al., 2016; Hochstenbach et al., 2016; Kummerow Broman et al., 2015; 
Sanger et al., 2016). Two included participants who were not patients or providers but were 
closely involved with them during the study period and could speak to their perspectives (Cohen 
et al., 2016; Sanger et al., 2016). 
Providers included physicians (surgeons, primary care physicians, specialists), nurses, 
advanced practice nurses, physician assistants, and dieticians. Their mean clinical experience 
ranged from 7 to 17 years. Patients’ mean ages ranged from 44 to 71 years old and gender 
breakdown ranged from 30% to 100% male. The study settings ranged from large, academic 
medical center to outpatient clinic. Eight of the 11 studies examined a specific tool to collect and 
use PGHD being tested. Qualitative data collection involved individual semi-structured 
interviews, open-ended survey questions, and observations. Quantitative data was collected 
through surveys and application usage reports. 
Characteristics of PGHD in Included Studies 
The characteristics of PGHD in the eight studies that tested an actual data tool are 
summarized in Table 2.2. PGHD included physiological, self-report, and passive sensor data 
targeting a wide range of clinical problems. PGHD was collected in a mobile format and/or 
through web-based platforms. Some tools allowed both patients and providers to visualize data 
while others only had a provider view. PGHD collection included manual entry into an 
application, automated entry from connected devices, photographs taken with digital cameras or 
mobile phones, text messaging, and a proprietary pen-and-paper technology. In five studies 
providers were the only intended users of PGHD, even if patients or their caregivers could view 
35 
the data. In these five studies, patients were reportedly not acting upon their data but deferring to 
the provider’s interpretation of it. 
Qualitative Synthesis 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Inter-rater reliability between the two coders was acceptable (kappa= 0.73). All coding 
discrepancies were discussed and resolved. 
Three high level themes emerged regarding patient/provider needs: clinical, logistic, and 
technological (Table 2.3). Thirteen sub-themes also emerged. Clinical sub-themes address 
patient-provider relationships, contextual metadata, and patient/provider needs for guidance. 
Logistic sub-themes address motivation and incentives, time, transparency, and provider 
preferences for patient selection. Technological sub-themes address customization, 
interoperability/EHR integration, data summaries, quality, security, confidentiality, and variation 
in features desired by patient/provider. A total of 48 distinct claims were extracted. Claims were 
grouped under one of the three major themes (16 clinical, 14 logistic, and 18 technological) and 
appropriate sub-theme (Table 2.3). Each claim was classified as convergent, divergent, or 
identified by only patients or only providers (Table 2.4). 
There are 20 convergent claims in which patients and providers both acknowledge a need 
and share similar views (8 clinical, 3 logistic, and 9 technological). This includes claims that 
pertain only to patient or to provider, but that both groups discuss. For instance, in a patient-
provider relationship, emotional needs are directly pertinent to the patient, but providers 
acknowledge that patient emotional needs must be met. 
There are 4 divergent claims that both groups discussed from opposing perspectives (0 
clinical, 3 logistic and 1 technological). For example, patients want a response to their PGHD 
within a few hours, while providers fear responding that quickly would disrupt their work. 
There are 5 claims identified only by patients (2 clinical, 1 logistic, and 2 technological). 
There are 19 claims identified only by providers (6 clinical, 7 logistic, and 6 technological). 
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Discussion 
Convergence and Divergence of Perspectives 
This integrative review identified three broad themes concerning patient and provider 
needs around collecting and using PGHD, from 11 primary sources of quantitative and 
qualitative data. Synthesis of the findings produced a set of 48 distinct claims. Half of the claims 
(24 of 48) were discussed by one group only, suggesting a mutual unawareness of each other’s 
needs. There were several points of convergence on claims pertinent to one group but 
acknowledged by the other. For example, patients acknowledged that providers need 
interoperability and EHR integration, and providers recognized that patients need education and 
guidance on PGHD collection. This suggests that collection and use of PGHD is a bi-directional 
relationship: patients and providers are cognizant of at least some of the other’s needs and are 
inextricably linked in the PHGD process. Thus well-designed informatics solutions must include 
capability for patients and providers to work with PGHD collaboratively, not in isolation. 
Unsurprisingly, there were many more instances of providers noticing a patient need than 
vice versa. This may reflect providers’ awareness of patient needs as a clinical skill, and of 
patients’ limited knowledge of provider workflows and clinical practices. For instance, all three 
claims that referred to time limitations were provider-generated; patients did not specify time as 
an issue in these 11 studies. 
An analysis of points of convergence and divergence found that patients and providers 
agree more about clinical and technological needs than they do about logistic needs. Our analysis 
suggests a general tension between patients needing more: more support, more guidance, more 
feedback on data, and providers needing less: less time burden, less data to review, less liability. 
There is also a suggestion that underlying anxieties surrounding PGHD and the health problems 
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for which it is collected are also at odds: patients are anxious to understand their health status, 
while providers are anxious about the implications of PGHD for their clinical practice, including 
liability, reimbursement, and time. Finally, the findings suggest that while patients want more 
flexibility with the data (which providers supported in some cases), providers still need methods 
for standardizing and limiting the data received. 
Sustained patient engagement as a major barrier 
Patients indicated that if the data and/or the tools to collect and view it did not meet their 
needs or produce some immediate benefit, their participation would be dampened or 
discontinued altogether. This corroborates recent evidence suggesting that sustained engagement 
with self-monitoring is a critical problem (Alkhaldi et al., 2016; Glasgow et al., 2011; Goyal et 
al., 2016). There is evidence that certain subsets of patients only collect data because providers 
ask them, rather than out of a natural curiosity or desire to learn (Dlugasch & Ugarriza, 2014; 
Lee, 2014). In 5 of the 8 studies that evaluated a tool, the PGHD was intended for provider use 
only (Table 2.4). As healthcare shifts to a patient-provider collaboration model (A. E. Chung & 
Basch, 2015; Nundy et al., 2012; Schroeder et al., 2017), research is needed on factors that 
contribute to sustained patient engagement with the process of collecting and using PGHD. 
Significance of this review 
Our analysis draws upon prior research that compared the perspectives of patients and 
providers on PGHD (Cheng et al., 2015; C. F. Chung et al., 2016; Hartzler et al., 2016; 
Hochstenbach et al., 2016; Kummerow Broman et al., 2015; Sanger et al., 2016), and extends 
that work by generating an integrated set of needs substantiated by multiple primary sources that 
may inform system requirements in future work. The findings of this review substantiate findings 
from a federally-commissioned report which relied on expert opinion (ONC, January 2018b), 
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with an analysis of primary source data from the two groups directly involved in collection and 
use of PGHD. Rich primary data from patients and providers offers increased validity and depth 
of understanding of the technical challenges, policy and reimbursement issues, need for clinical 
guidelines, and lack of sustained engagement by patients recording PGHD. Furthermore, by 
analyzing patient and provider needs in relation to each other, points of convergence and 
divergence emerged. This information may be applied to developing systems to improve the 
collection and use of PGHD through accommodating the needs of both user groups, thereby 
potentially increasing the likelihood of success. 
Implications for policy and design 
Overall the findings suggest that expectations should be set between patients, providers, 
and other relevant stakeholders (e.g., administrators, reimbursing agencies, technology vendors) 
from the very beginning of the process–including identifying and reconciling differences in those 
expectations. Transparency in this process may be an approach to avoid frustration and 
confusion. Goals for collecting and using PGHD need to be explicit, as our findings illustrate 
that these can be different. Technology vendors are advised to follow best practices for engaging 
patients and providers in specifying system requirements for flexibility, standardization, 
visualizations, messaging, data summarization, and integration before implementing a tool 
(AHRQ, 2012; HHS, 2017). Administrators can identify and seek to mitigate workflow barriers 
such as scheduling, role delegation, and scope of practice. Policymakers should analyze current 
incentive structures for patients and reimbursement for providers. Future research that examines 
health outcomes and cost-benefit of PGHD compared to standard care can produce the evidence 
to drive policy towards incentivizing the collection and use of PGHD. 
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Conclusion 
Patients and providers share many common needs when collecting and using PGHD in 
practice. These needs are clinical (maintain a relationship, data interpretation, contextual 
metadata), logistic (motivation, negotiation, convenience/usability, and transparent provider 
roles), and technological (customizable visualizations, flexible data input, electronic integration, 
simple actionable data summaries, and management of data quality and security concerns). 
Differences between patients and providers arose in these three main categories as well, mainly 
centering on patients’ needs for reassurance, instruction, and communication with providers, as 
compared to providers’ needs to limit scope of PGHD, standardize it, receive it from only certain 
patients (in many cases), and have clear clinical guidelines to follow in responding to it. 
Patients and providers are the two primary stakeholders directly involved with PGHD 
collection and use, and their needs in this process are inextricably linked. As momentum gains 
for PGHD to become fully integrated into the healthcare system, these perspectives are critical to 
ensure their needs are concurrently being met. 
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Chapter Three: A Theory-Driven Exploration of Factors Associated with Sustained ECG 
Self-Monitoring in a Post-Intervention Atrial Fibrillation Population
In Chapter Three, the second aim of this dissertation is addressed in a quantitative 
secondary data analysis evaluating associations between predictors and moderators from the 
adapted UTAUT model and use of ECG mHealth technology over one year. The target journal 
for this manuscript is the Journal of Cardiovascular Nursing. 
Abstract 
Background: Self-monitoring using electrocardiogram mobile health (ECG mHealth) has the 
potential to improve detection, treatment, and management of atrial fibrillation (AF). However, 
there is evidence that sustained engagement with mHealth is low, and little research has 
examined reasons for low engagement, preventing the benefits of self-monitoring for adults with 
AF from being realized. 
Objective: To describe engagement, as well as predictors and moderators, with mHealth 
technology among adults with AF during the first year of use. 
Methods: We conducted a secondary analysis of data from adults with AF enrolled in the 
iHEART trial who used ECG mHealth to self-monitor. Hierarchical generalized linear modeling 
was used to characterize AliveCor™ use, a measure of engagement with mHealth, over one year, 
and identify possible predictors and moderators of AliveCor™ use that came from an adapted 
version of the Unified Theory of Acceptance and Use of Technology (UTAUT). 
Results: We evaluated 132 adults with AF (mean age 62, 77% male). Subjects who experienced 
more frequent AF episodes had 87% more AliveCor™ use over one year than those who 
experienced fewer episodes. Perceived usefulness and AF knowledge were also associated with 
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AliveCor™ use. We also found evidence of complex relationships between the distinct variables 
in the adapted UTAUT model. 
Conclusions: Patients who can view and understand their own data (as subjects could with 
“frequency of AF episodes” in this study) may be more engaged with self-monitoring via ECG 
mHealth technology over time. Due to limitations of secondary data, the complex relationships 
between variables in the adapted UTAUT model may be better evaluated using data captured at 
the time of most reliable data, such as during an ECG recording with mHealth. 
Background and Significance 
Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical 
practice, affecting between 2.7 and 6.1 million people in the United States (CDC, 2015). 
However prevalence estimates vary enormously due to difficulty detecting AF in “real world” 
settings, and current approaches for detecting and managing AF typically include brief (24-72 
hours) ECG monitoring and prescheduled health visits (Turakhia & Kaiser, 2016). These 
approaches are often inadequate given the sporadic, unpredictable nature of the arrhythmia, so 
that AF often goes undetected and thus untreated (Olgun Kucuk et al., 2015; Turakhia & Kaiser, 
2016). Failure to detect and treat AF can lead to heart failure, myocardial infarction, stroke, and 
death (Olgun Kucuk et al., 2015). In fact, stroke is one of the most disabling first presentations of 
undetected AF (Jaakkola et al., 2016). As such, AF represents a major public health problem, 
accounting for more than 750,000 hospitalizations, 130,000 deaths, and $6 billion in costs each 
year (CDC, 2015). 
Mobile health technology (mHealth) is a promising approach to detect AF in a timelier 
manner. As of 2018, 77% of adults in the U.S. own a smartphone and these rates are similar 
across gender, race/ethnicity, income, and geographic region (Pew, 2018). Timely detection is 
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needed to restore normal sinus rhythm earlier, improve disease management through medication 
and lifestyle adjustments, and reduce health risks of AF such as hospitalization, stroke, or death 
(Olgun Kucuk et al., 2015; Steinhubl et al., 2016). mHealth technologies, such as smartphones 
and mobile devices, are ideal for assisting with self-management because they are convenient, 
affordable, and widely used by many Americans (Bender et al., 2014; Pew, 2018). ECG mHealth 
technology, such as the AliveCor™ device, allows individuals with AF to easily record and 
transmit an ECG to their healthcare provider for review using a device that works with 
smartphones. Studies have demonstrated that this technology can accurately detect and identify 
arrhythmias such as AF (McManus et al., 2016; Steinhubl et al., 2016), and therefore has the 
potential to assist patients with AF through timely detection of AF episodes. 
However, a major barrier to timely AF detection is low sustained engagement with 
mHealth. Measures of mHealth use over an extended period of time show that many users 
discontinue use within three to six months of initiation, suggesting low sustained engagement 
(Coa & Patrick, 2016; Glasgow et al., 2011; Mattila et al., 2013). This is a critical issue for 
individuals with AF, because they must regularly record and transmit ECG data to healthcare 
providers in order for AF to be detected and treated in a timely manner (Steinhubl et al., 2016; 
Turakhia & Kaiser, 2016). The spontaneous, unpredictable nature of AF and its high rates of 
recurrence after an intervention to restore normal sinus rhythm make sustained engagement all 
the more critical for individuals with AF (Olgun Kucuk et al., 2015; Steinhubl et al., 2016). 
Little is known about approaches to improve sustained engagement. Much of the existing 
research on user engagement focuses on strategies to improve initial uptake rather than sustained 
engagement (Ford et al., 2015; Lasorsa et al., 2016). Those that have focused on mHealth 
features, such as gamification and incentives, rather than the user, have largely failed to sustain 
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user engagement (King et al., 2013; Shimada et al., 2016). Recent studies have uncovered 
correlates of sustained engagement, but these vary widely between studies and range from 
individual characteristics (age, gender, disease characteristics, motivation, experience with 
technology) to technology-related characteristics (ease of use, usefulness) (Alkhaldi et al., 2016; 
Hermsen, Moons, Kerkhof, Wiekens, & De Groot, 2017; Sharpe, Karasouli, & Meyer, 2017). In 
some cases study findings contradict one another, as in the case of younger versus older age in 
relation to sustained engagement (Mattila et al., 2013; Pavliscsak et al., 2016; Shimada et al., 
2016). As such, there remains a lack of a clear framework for understanding and intervening 
upon sustained engagement. 
Therefore, we take a unique approach by guiding our investigation with a relevant theory. 
The Unified Theory of Acceptance and Use of Technology (UTAUT) is a validated model that 
considers individual characteristics in predicting technology acceptance and use (Venkatesh et 
al., 2003). UTAUT is widely used in other applied technology settings (e.g., business, education) 
and is increasingly being used in healthcare (Attuquayefio & Addo, 2014). In this study, we used 
an adapted UTAUT model that is based on a model previously used to explain sustained 
engagement with mHealth among an acute post-surgical population of lung transplant recipients 
(Jiang et al., 2016). The specific “facilitating conditions” that Jiang et al. (2016) measured were 
chosen based on the study population, and we tailored this variable as well. 
In the adapted UTAUT model (Figure 3.1; see Figure 1.2 for full-size image), the 
outcome of interest is sustained engagement with ECG mHealth technology. The adapted 
UTAUT model contains three independent predictors of technology use. These are perceived 
usefulness, perceive ease of use, and facilitating conditions: severity of AF symptoms, frequency 
of AF episodes, and AF knowledge. Additionally there are three independent moderators of 
53 
technology use: age, gender, and experience with technology. Age and gender independently 
moderate the effect of all independent predictors on the outcome. Experience with technology 
only moderates the effects of perceived ease of use and perceived usefulness. 
Figure 3.1: The adapted UTAUT model 
Objectives 
Using self-monitoring with AliveCor™ as a use case for sustained engagement, the 
overall purpose of this study was to describe engagement over time among adults with AF self-
monitoring using ECG mHealth technology. Specifically, we aimed to: (1) describe engagement 
with self-monitoring during the first year after an intervention to restore normal sinus rhythm to 
the heart, (2) identify possible predictors of sustained engagement with self-monitoring over one 
year, and (3) identify possible moderation effects of age, gender, and experience with technology 
on relationships between hypothesized predictors and sustained engagement with self-
monitoring. 
Methods 
Study Design and Sample 
We conducted a secondary analysis of data collected during a single center, randomized, 
controlled trial (RCT) called iPhone® Helping Evaluate Atrial Fibrillation Rhythm through 
Technology (iHEART, R01NR014853, PI: Hickey). The original iHEART sample consists of 
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adults with a history of AF. Inclusion criteria in the original iHEART trial are English or Spanish 
speaking, age 18 or older, and have a history of AF in the last 30 days for which treatment 
successfully restored normal sinus rhythm (Hickey et al., 2016). Exclusion criteria are 
documented permanent or chronic AF, and patient found to be unstable or have other 
arrhythmias on day of enrollment. 
iHEART trial participants are randomized 1:1 to receive either usual cardiac care (control 
group) or usual care plus mHealth (intervention group). Specifically, participants randomized to 
the intervention arm received an iPhone® and cellular service plan with unlimited data/text 
messaging and the AliveCor™ Mobile ECG device. The AliveCor™ device is FDA-approved 
and captures a highly sensitive (98%), specific (97%), and accurate (97%) single-lead ECG 
recording (Hickey et al., 2016). ECGs are recorded when the user places his or her fingertips on 
the AliveCor™ device. This device is novel in that previous non-invasive remote ECG monitors 
must be worn by the patient and often are too cumbersome for extended use, thus limiting the 
window of time for arrhythmias to be detected (Olgun Kucuk et al., 2015; Turakhia & Kaiser, 
2016). 
ECG recordings captured with the AliveCor™ device are documented in a free 
accompanying smartphone application (app), Kardia®, and are automatically uploaded via WiFi 
or cellular network transmission to the HIPAA-compliant, secure AliveCor™ cloud. An 
algorithm in the Kardia® app uses the regularity of R-to-R intervals and presence or absence of 
p-waves in an ECG to identify the rhythm of each recording as either normal sinus rhythm, atrial 
fibrillation, or “unclassified,” meaning the algorithm could not identify the rhythm (Javed, 
Ahmad, Albert, & Stavrakis, 2018). The rhythms identified by the algorithm are reviewed and 
confirmed by a cardiologist. Other arrhythmias unknown to the algorithm can be manually 
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identified by viewing the 30-second rhythm strip of the recording. Study coordinators trained in 
ECG interpretation review AliveCor™ data daily through a secure portal and immediately send 
clinically significant arrhythmias to the participant’s healthcare provider, and are responsible for 
follow-up. During the iHEART trial, all participants received in-person training on use of the 
device prior to enrollment. 
In this study, we specifically examined data from the iHEART participants who were 
randomized to the intervention group and have completed the trial. Inclusion criteria for the 
quantitative analysis were: (1) randomized to the intervention group in the iHEART trial (and 
therefore used AliveCor™), and (2) completion of iHEART study including six-month follow-up 
surveys (for data completeness). 
The study protocol approved by the institutional review board at Columbia University 
Medical Center (CUMC, Protocol AAAR3165). 
Data sources and Measures 
Data came from the secure AliveCor™ database and surveys/demographic measures 
contained in a separate iHEART database. Appendix B contains a summary of the variables from 
the adapted UTAUT model and data sources used in this analysis, and Appendix C contains the 
iHEART trial surveys providing data for this analysis. We collaborated with account executives 
at AliveCor™ to coordinate an export of iHEART participants’ data in January 2018. The export 
included images of each rhythm strip that participants captured with AliveCor™ and a file of 
each user’s dated, time-stamped ECG transmissions with heart rhythm identified by the Kardia® 
algorithm for each transmission. Survey data was collected on paper-based surveys at baseline 
and six months. Participants completed surveys in person at CUMC, or at home and returned 
them by mail. Study coordinators entered responses into a secure iHEART database that is 
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separate from the AliveCor™ database. We exported survey and demographic data directly from 
the iHEART database. 
 Each of the variables except the outcome (use of AliveCor™) was transformed into a 
binary variable to improve model efficiency and allow for easier comparison of incidence rate 
ratios (IRR) in models with interaction terms. Mean and median values of each variable were 
consulted in creating its binary form. 
Outcome: Use of AliveCor™ for self-monitoring. In this study, ECG recordings are a 
proxy for the outcome variable, AliveCor™ use over time. We selected a one-year time frame of 
AliveCor™ use after examining descriptive statistics of usage data, which showed that many 
participants continued using the device after completing the six-month iHEART trial. We chose 
not to include all usage data because the few participants who used AliveCor™ for several years 
would have skewed the outcome variable appreciably. To account for rolling recruitment in the 
iHEART trial, we normalized each participant’s start date to “day zero.” We then calculated the 
number of recordings in each seven-day period since first use (e.g., week one, week two, etc.) to 
create the variable: count of ECG recordings per week. Monthly use was calculated using the 
same process, and histograms of counts of daily, weekly, and monthly use were compared. The 
distributions of daily and monthly use were highly skewed, so weekly use was used in analyses. 
Perceived Ease of Use and Perceived Usefulness. Data for perceived ease of use and 
perceived usefulness came from the iHEART Patient Experience Survey, which is administered 
to all participants randomized to the iHEART intervention at study completion (six months). It 
inquires about the patient’s experience using AliveCor™ during the trial. Perceived usefulness is 
a binary variable measured according to the individual’s response (“yes/no”) to the question: 
“Do you feel the device is beneficial?” Perceived ease of use was measured according to the 
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individual’s responses to eight Likert-type questions on perceived ease of use of various aspects 
of the technology (for example, portability). Response options range from one (poor) to five 
(great). Overall ease of use was calculated as the mean of the responses to these eight questions. 
It was then converted into a binary variable based on the mean score (less than or equal to three 
indicates low perceived ease of use, greater than three indicates high perceived ease of use). 
Facilitating Conditions. Data for Severity of AF Symptoms came from the individual’s 
class of AF severity on Canadian Cardiovascular Society Severity in Atrial Fibrillation scale 
(CCS- SAF, Cronbach’s α 0.81). This scale queries the individual’s symptoms and impact on 
quality of life, and places them in a “class” of AF severity, ranging from 0 (asymptomatic) 
through 4 (severe effect of symptoms on individual’s quality of life) (Harden et al., 2009). This 
survey was administered at baseline and study completion (six-months), however due to a large 
amount of missing data from study completion surveys, only baseline CCS-SAF data was used in 
this analysis. Participants’ CCS-SAF class was converted into a binary variable in which classes 
zero and one indicate low severity, and classes two through four indicate high severity. 
AF Knowledge was assessed using the AF Knowledge Survey (Cronbach’s α 0.58). This 
survey contains 11 items concerning AF in general, symptom recognition, and treatment 
(Hendriks, Crijns, Tieleman, & Vrijhoef, 2013). AF Knowledge was measured as the number of 
correct answers out of 11. This survey was administered at baseline and study completion, 
however similar to CCS-SAF surveys, only baseline data was used due to missing data at study 
completion. This was converted into a binary variable in which zero through seven correct 
answers indicate low AF knowledge, and eight through eleven correct answers indicate high AF 
knowledge. 
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Frequency of AF Episodes was assessed using the cardiac rhythm of each ECG recording 
(e.g., normal, AF, or unclassified) identified by the Kardia® algorithm and documented in the 
AliveCor™ database. The frequency of AF episodes was calculated as the average number of AF 
episodes per week over the first year of use. The weekly average provided adequate granularity 
for demonstrating frequency based on preliminary data. For the final binary variable, an average 
of less than or equal to one AF episode per week was considered low frequency, and greater than 
one AF episode per week was considered high frequency. 
Age and Gender. Age was calculated by the birthday reported on the patient’s electronic 
medical record. This was converted into a binary variable in which age less than or equal to 62 
years old indicated younger age, and age greater than 62 years old indicated older age. Gender 
was recorded as the individual’s stated gender on demographic surveys. None of the participants 
reported a non-binary gender. 
Experience with Technology. Experience with technology was recorded for iHEART 
study participants at baseline using a survey with ten “yes/no” questions about ownership and 
use of various technologies (smartphones, Internet, text messaging). We categorized experience 
according to the number of “yes” responses out of ten. A binary variable was created with eight 
or greater “yes” responses indicating experience and fewer than eight “yes” responses indicating 
a lack of experience. 
Data Analysis 
The outcome variable to represent participants’ overall engagement with technology is 
the weekly count of incidents of AliveCor™ use (i.e. ECG transmissions) from baseline to one 
year, and the main predictor is time (measured in weeks, from baseline to one year). Other 
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predictors come from the adapted UTAUT model: perceived ease of use, perceived usefulness, 
severity of AF symptoms, AF knowledge, and frequency of AF episodes. 
All identifiable information was removed prior to statistical analysis. Next, descriptive 
statistics of frequency, dispersion, and central tendency were calculated to characterize the 
sample and AliveCor™ use. Missing data were then evaluated for randomness. Because we only 
used baseline data for most of the predictors and moderators, missing data are not related to the 
participants’ engagement and therefore are missing completely at random (MCAR). Two 
variables, perceived ease of use and perceived usefulness, were assessed only at six-month 
follow up because it required the participant to reflect on their perceptions of AliveCor™. This 
missing data was therefore potentially non-random and is a limitation of the analysis. 
After evaluating missing data, hierarchical generalized linear modeling (HGLM) with 
Poisson distribution was used to estimate parameters of AliveCor™ use over time. This approach 
was chosen because the outcome is a repeated measure (count of incidents of use) and we were 
interested in examining changes over time (Dickey, 2010). First, the linear, quadratic, cubic 
models of AliveCor™ use over time (i.e., linear, quadratic, and cubic terms of time as 
independent variables) were evaluated. The quadratic and cubic models did not provide estimates 
and the linear term was used for subsequent analyses. Second, relationships between each 
predictor from the adapted UTAUT model and AliveCor™ use were tested in bivariate models 
(week plus one predictor). During this step, moderators (age, gender, and experience with 
technology) were also tested as main effects in bivariate models. Only predictors with p<0.25 in 
bivariate analyses were included in a final parsimonious model (Bendel, 1977; Mickey & 
Greenland, 1989). Third, moderators were tested in multivariate models (main effects plus one 
interaction term). The significance level was set at p<0.10 for exploration of moderation effects 
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(Baron & Kenny, 1986). Finally, the parsimonious model was iteratively run until all predictors 
were significant at the p<0.05 level. 
For reporting purposes, β estimates from HGLMs were converted to person-time 
incidence rate ratios (IRR) using the formula: [exp(β)]. IRR are an approach for understanding 
the number of new incidents of a phenomenon in a population over a given time period (Dicker, 
Coronado, Koo, & Parrise, 2006). IRR are described in the results as the percent difference in 
AliveCor™ use between high and low values of a predictor. These percent difference estimates 
were calculated using the following formula: [exp(β) – 1] x 100 (Dicker et al., 2006; Gaskins, 
Sundaram, Buck Louis, & Chavarro, 2018). 
All statistical analyses were conducted using SAS statistical software version 9.4 (SAS 
Institute, Inc., Cary, NC). 
Results 
Description of the Sample 
 Table 3.1 shows descriptive statistics for 132 iHEART participants who had completed 
the intervention arm of the trial. Study participants were 62 years old on average and 
predominantly male, White, and English-speaking. Demographic information such as income or 
education level is not available through the iHEART trial database. Study participants had a 
mean body mass index (BMI) of 29 kg/m2. Participants’ mean ejection fraction (percentage of 
ventricular blood pumped with each contraction, an indicator of cardiac functioning) was 52%. 
The mean CHADS2 score, which predicts likelihood of stroke based on past medical history and 
age, was 1.88. Common co-morbid conditions among participants were hypertension (75%), 
coronary artery disease (43%), sleep apnea (40%), and anxiety (27%). Nearly all participants 
61 
reported that they owned a smartphone (91%) and a computer or tablet (93%), had high-speed 
Internet access at home (96%), and were comfortable browsing the Internet (99%). 
Table 3.1: Summary of Sample Characteristics (n=132) 












Gender (male) 101 
(132) 
77 
Race (white) 89 (105) 85 












CHADS2 score 1.88 (1.36) 0-5 
Procedure on enrollment 
(ablation) 
35 (65) 54 
Comorbid Conditions 
Coronary artery disease 18 (42) 43 
Sleep apnea  14 (35) 40 
Hypertension  30 (40) 75 
Diabetes Mellitus 4 (35) 11 
Heart Failure 8 (53) 15 
TIA or stroke 7 (43) 16 




Own cell phone 75 (76) 99 
Own smartphone 69 (76) 91 
Use smartphone to browse 
Internet 
64 (76) 84 
Use smartphone for email 62 (76) 82 
Ever download smartphone app 
w/o assistance 
59 (75) 79 
Send/receive text messages 73 (77) 95 
Ever followed link to website 
from text message 
59 (77) 77 
Access and use computer or 
tablet at home 
70 (75) 93 
High speed Internet access at 
home 
74 (77) 96 
Comfortable using computer to 
browse Internet 
75 (76) 99 
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*Accounts for missing data
Description of AliveCor™ Use 
Table 3.2 shows descriptive statistics of the study participants’ AliveCor™ use over one 
year. The iHEART protocol asked participants to transmit at least once daily for six months, or a 
minimum target of 30 transmissions per person per month. Among 132 participants, 76 (58%) 
used the device for the entire six-month iHEART trial. After one year, 55 participants (42%) 
were still using the device. The mean transmissions per person per month was about 23 after one 
month, 32 after six months, and 20 after one year. The median transmissions per person per 
month was 9 after one month, 12 after six months, and 9 after twelve months. 
Heart Rhythm Data collected with AliveCor™ 
Table 3.3 shows the number ECG transmissions by participants over the one-year period 
in sum and stratified by rhythm type per the Kardia® algorithm. In total the 132 participants 
recorded 36,810 ECGs with AliveCor™ over one year. The percentage of transmissions 
Table 3.2: Descriptive statistics of the study participants’ AliveCor™ use over one year 
(n=132) 
Month 
Active users for entire month Transmissions per person per 
month 
Number (n) Percentage of Total (%) Mean SD Median 
1 111 84 23.02 40.41 9 
2 104 79 21.80 46.03 6 
3 96 73 23.73 50.26 6 
4 88 67 22.84 45.54 7 
5 79 60 26.24 47.40 8 
6 76 58 32.41 54.55 12 
7 79 60 31.02 54.76 9 
8 69 52 35.73 58.27 9 
9 68 52 28.92 51.35 9 
10 63 48 29.45 55.56 8 
11 57 43 24.80 52.25 9 
12 55 42 20.35 40.27 9 
  63 
identified by the algorithm as normal sinus rhythm was 37% after one month, 44% after six 
months, and 47% after one year. The percentage of transmissions identified as atrial fibrillation 
was 12% after one month, 8% after six months, and 16% after one year. The percentage of 
transmissions that the Kardia® algorithm was unable to identify (“unclassified”) was 51% after 
one month, 48% after six months, and 37% after one year. 
We also examined the proportion of participants who experienced each type of heart 
rhythm during each month. The percentages were not mutually exclusive because users may 
have experienced more than one rhythm type during a given month. The percentage of users with 
normal sinus rhythm per the Kardia® algorithm was 71% after one month, 75% after six months, 
and 73% after one year. The percentage of users with atrial fibrillation per the Kardia® 
algorithm was 42% after one month, 38% after six months, and 24% after one year. The 
percentage of users with “unclassified” transmissions was 92% after one month, 50% after six 
months, and 27% after one year.  
 
Table 3.3: The number and percentage of ECG transmissions collected by participants 
over the one-year period in sum and stratified by rhythm type identified by the Kardia® 
algorithm 
Aggregated by ECG Transmissions (n=36,810) 
Month Total  
Normal Sinus 
Rhythm  
Atrial Fibrillation  Unclassified  
 n n % n % n % 
1 6,392 2,385  37 768 12 3,239 51 
2 4,703 1,888 40 528 11 2,287 49 
3 3,712 1,617 44 391 11 1,704 46 
4 3,175 1,333 42 340 11 1,502 47 
5 3,208 1,217 38 394 12 1,597 50 
6 3,029 1,326 44 242 8 1,461 48 
7 2,812 1,294 46 218 8 1,300 46 
8 2,716 1,303 48 249 9 1,164 43 
9 2,213 1,269 57 176 8 768 35 
10 1,729 966 56 177 10 586 34 
11 1,536 829 54 159 10 548 36 
12 1,585 745 47 260 16 580 37 
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Atrial Fibrillation Unclassified 
n n % n % n % 
1 111 79 71 47 42 102 92 
2 104 76 73 39 38 90 68 
3 96 68 71 34 35 81 61 
4 88 63 72 28 32 74 56 
5 79 61 77 27 34 68 52 
6 76 57 75 29 38 66 50 
7 79 58 73 26 33 56 42 
8 69 54 78 23 33 57 43 
9 68 55 81 15 22 46 35 
10 63 48 76 19 30 47 36 
11 57 47 82 22 39 40 30 
12 55 40 73 13 24 36 27 
*Percentages are calculated using the number of active users during the month (not all
users) 
Simple Linear Model of Association between Time (Week) and AliveCor™ Use 
Figure 3.2 shows the simple linear model of the association of time and AliveCor™ use 
over one year. The parameters for this model are reported in Table 3.4. The model shows a 
statistically significant but not meaningful decline in AliveCor™ use over time (IRR= 1.00; 
p<0.01) among all iHEART trial intervention arm participants. 
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Predictors of AliveCor™ use 
The main effects of perceived usefulness, severity of AF symptoms, AF knowledge, 
frequency of AF episodes, and experience with technology tested in bivariate models were 
significant at the p<0.25 level (Table 3.4). Subjects who perceived AliveCor™ as useful 
recorded 50% more incidents of AliveCor™ use than those who did not perceive the device as 
useful. Subjects who reported greater severity of AF symptoms recorded 36% more incidents of 
AliveCor™ use than those who reported less severity. Subjects who had more AF knowledge 
recorded 28% more incidents of AliveCor™ use than those who had less knowledge. Subjects 
who experienced more frequent AF episodes recorded 94% more incidents of AliveCor™ use 
than those who experienced fewer episodes. Subjects who reported greater experience with 
















Simple Hierarchical Generalized Linear Model: 
AliveCor™ Use Over One Year










































































































































































































































































































































































































































































































































































































































































































































































Final Parsimonious Model 
Construction of a final parsimonious model was based on significance levels of the 
associations for each variable (Table 3.4). The initial iteration included severity of AF 
symptoms. This variable was removed for p>0.05 and β=0, and results are reported in Table 3.5. 
Perceived usefulness, AF knowledge, and frequency of AF episodes were significantly related to 
AliveCor™ use at the p<0.05 level. Subjects who perceived AliveCor™ as useful recorded 57% 
more incidents of AliveCor™ use than those who did not perceive the device as useful. Subjects 
who had more AF knowledge recorded 48% more incidents of AliveCor™ use than those who 
had less knowledge. Subjects who experienced more frequent AF episodes recorded 87% more 
incidents of AliveCor™ use than those who experienced fewer episodes. 
Experience with technology was not significantly related to AliveCor™ use but was 
collinear with perceived usefulness and AF knowledge in the parsimonious model. When it was 
removed from the model, there was a large (>10%) change in the β estimates of perceived 
usefulness and AF knowledge and these variables became insignificant at the p<0.05 level. An 
analogous change in β estimates was observed when comparing bivariate (i.e., week and 
perceived usefulness or AF knowledge) and multivariate models (i.e., week, experience with 
technology, and perceived usefulness or AF knowledge). The β estimate of frequency of AF 
episodes did not change when experience with technology was removed and the variable 
remained significant at the p<0.05 level. 
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Moderation Effects 
Hypothesized moderators of AliveCor™ use specified by the adapted UTAUT model 
(age, gender, experience with technology) were tested in multivariate models (main effects plus 
one interaction term). The following models testing interactions did not converge even when less 
stringent convergence criteria was specified: perceived usefulness with age and with experience 
with technology, frequency of AF episodes with age and with gender, and perceived ease of use 
with gender and with experience with technology. The remaining models were not significant at 
the p<0.10 level. Therefore none of the hypothesized moderators were reported. 
Additionally, we tested the interactions between week and high versus low values for 
each predictor (Table 3.6). The models testing the interactions of week with perceived ease of 
use and with severity of AF symptoms did not converge even when less stringent convergence 
criteria was specified. These models were therefore not reported. Although the remaining 
interactions were statistically significant at the p<0.10 level, the differences in IRR between 
different values of the interaction term were extremely small and did not warrant inclusion in the 
final parsimonious model. 
Table 3.5:  Parsimonious Model of Associations between variables in the adapted UTAUT 
model and AliveCor™ Use over One Year with Person-Time Incidence Rate Ratios 
Effects β IRR 95% CI p 
Week 0.002 1.00 (1.00, 1.00) <0.01 
Perceived Usefulness 0.45 1.57 (1.07, 2.30) 0.02 
AF Knowledge 0.39 1.48 (1.13, 1.94) <0.01 
Frequency of AF 
Episodes 
0.63 1.87 (1.85, 1.89) <0.01 
Experience with 
Technology 
-0.16 0.85 (0.35, 2.06) 0.73 
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Discussion 
We conducted a secondary analysis of data from the AliveCor™ smartphone device and 
survey data from 132 adults with AF who completed the intervention arm of the iHEART study. 
We found that subjects who experienced more frequent AF episodes reported 87% more 
incidents of AliveCor™ use over one year than those who experienced fewer episodes. We also 
found that subjects who perceived the device as useful reported 57% more incidents of 
AliveCor™ use than those who did not perceive it as useful. Finally, we found that subjects who 
had more AF knowledge reported 48% more incidents of AliveCor™ use than those who had 
less knowledge. However the nature of these relationships is difficult to assess due to limitations 
in the data and the sample of subjects. 
Table 3.6: Person-time Incidence Rate Ratios of Associations between Interactions of 
variables in the adapted UTAUT model with Time (Week) and AliveCor™ Use over One 
Year 
Interaction Term Effects IRR p 
Perceived Usefulness * 
Week 
Low Perceived Usefulness 0.98 
<0.01 
High Perceived Usefulness 1.00 
AF Knowledge * Week 
Low AF Knowledge 0.99 
<0.01 
High AF Knowledge 1.00 
Frequency of AF Episodes 
* Week
Low Frequency of AF Episodes 1.00 
<0.01 
High Frequency of AF Episodes 1.01 
Age * Week 
Younger Age (< 62 years) 1.00 
<0.01 
Older Age (>62 years) 0.99 





Technology * Week 
Low Experience with Technology 1.00 
<0.01 
High Experience with Technology 1.00 
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The data from survey responses (used to measure all predictor variables except frequency 
of AF episodes) were collected at a single time point, thereby failing to capture fluctuation over 
time. There were also missing data due to ongoing processes in the parent study. As we have 
explained, most missing data were MCAR except for two variables: perceived ease of use and 
perceived usefulness, which were missing due to loss to follow up. This missing data was likely 
non-random and may have biased our analysis toward higher perceived ease of use and 
usefulness, because those who were lost to follow up may have been less engaged due to low 
perceived ease of use and usefulness. Finally, we quantified engagement as AliveCor™ use, 
which was based on ECG transmissions, but we did not have access to data on participants’ use 
of other functions of the Kardia® app, such as messaging healthcare providers and reviewing 
past data. Therefore some participants’ engagement may have been underestimated depending on 
the features they preferred to use.  
These data limitations cause us to conclude that secondary analysis of survey data 
collected for other purposes may not have adequate content validity to fully characterize 
AliveCor™ use. For example, the simple linear model showed no meaningful difference in 
AliveCor™ use over time. However there were wide disparities between the mean and median 
number of transmissions per person per month, and large standard deviations from the mean 
(Table 3.2), indicating differences within the sample but no stable pattern of AliveCor™ use 
overall. Additionally, frequency of AF episodes was the only variable that was not captured via 
survey, and it was consistently significantly associated with AliveCor™ use over one year. This 
variable was calculated based on AF rhythms identified by the Kardia® algorithm and was 
therefore captured at extremely high frequencies. Future research should explore measurement of 
constructs from the adapted UTAUT model at the time of the most reliable data, which is likely 
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at the time of transmission. Data capture via smartphone app may improve upon the limitations 
of survey data (e.g., missing values, recall bias, inadequate frequency of data capture). 
Ecological momentary assessment (EMA) is one emerging approach for capturing real-time data 
via smartphone that could overcome such limitations (Hand & Perzynski, 2016; Juengst et al., 
2015; Shiffman, Stone, & Hufford, 2008). 
Our findings highlight complex relationships between the distinct variables in the adapted 
UTAUT model in this unique patient population. Many of the significant independent 
associations between variables from the adapted UTAUT model and AliveCor™ use later 
dampened when entered together in the final parsimonious model. However none of the adapted 
UTAUT moderators (age, gender, experience with technology) significantly moderated any 
predictors’ relationships with AliveCor™ use. We detected collinearity between perceived 
usefulness, AF knowledge, and experience with technology in the final parsimonious model. Yet 
experience with technology and AliveCor™ use were negatively associated, indicating that users 
with less technology experience had more incidents of AliveCor™ use over time. Together these 
variables may be revealing a phenomenon that we were unable to directly measure with the data. 
However, such a conclusion must be considered in light of selective criteria of the parent 
RCT, which sought to limit the variability of participants with respect to demographic 
characteristics, health status, experience with technology, and engagement in their care. To be 
enrolled in iHEART, participants must have undergone a procedure (cardioversion or 
radiofrequency ablation) to restore normal sinus rhythm to the heart. This invasive treatment may 
have influenced participants to become more engaged in their care than a patient pursing medical 
management alone (e.g., medications). Moreover, to be enrolled participants had to agree to use 
AliveCor™, which may have excluded subjects who were less comfortable with technology. 
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Overall, our findings corroborate prior studies that characterize the relationships between 
variables associated with sustained engagement as complex and unique to the patient population 
being studied (Hermsen et al., 2017; Park et al., 2018; Sharpe et al., 2017). For instance, clinical 
research has demonstrated that gender, age, severity of AF symptoms, and frequency of AF 
episodes are interrelated in adults with AF (Dagres et al., 2007; Kaiser et al., 2016; Lip et al., 
2015). The complex relationships between variables from the adapted UTAUT model, and the 
influence of these interrelationships on sustained engagement, should be explored in future 
research using more complete data collected at more frequent time points. 
Frequency of AF episodes was the only variable for which iHEART participants could 
view their results, as they could immediately see the rhythm identified by the algorithm through 
the Kardia® app. Moreover, there was a slight increase in the number of AF transmissions 
towards the end of the one-year period, while the number of users with AF transmissions 
declined (Table 3.3). This may suggest that the few users who continued to experience AF 
documented it more frequently with AliveCor™ over time. One possible interpretation is that 
visualizing one’s own data and, through it, understanding current health status, may be a 
powerful motivator for continued use of mHealth technologies. Others have found preliminary 
evidence that viewing and understanding one’s own self-monitoring data is a motivating factor in 
sustaining engagement with self-monitoring (Miyamoto et al., 2016; Muessig et al., 2014; Sharpe 
et al., 2017). This is an approach that has yet to be well explored and warrants future 
investigation given the explosion of available PGHD in recent years (Lai et al., 2017; Wood et 
al., 2015). 
Our findings also suggest that AF knowledge and perceived usefulness, which are 
modifiable factors, are related to AliveCor™ use. mHealth design is one approach to target these 
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factors. For instance, educational modules can be embedded in applications to enhance AF 
knowledge. Consistent with the interpretation that health data presented back to the user may 
motivate further self-monitoring, an individual’s own data can serve to increase AF knowledge, 
as well. For example, data can be used to teach patients about the well-documented poor 
correlation between AF episodes and perceived symptoms (Barrett et al., 2014; Simantirakis et 
al., 2017). These data could also increase perceived usefulness by demonstrating how continued 
self-monitoring positively influences an individual’s health outcomes. Qualitative research with 
AliveCor™ users may uncover additional design opportunities to target AF knowledge and 
perceived usefulness. 
Conclusion 
In this study we found some qualified evidence of differences in AliveCor™ use among 
adults self-monitoring AF using ECG mHealth technology. Additionally, we found some 
evidence validating the predictors in the adapted UTAUT model in relation to AliveCor™ use. In 
future work approaches for frequent, real-time data capture through mHealth technology, such as 
EMA, may provide more robust data for the adapted UTAUT model to be evaluated in the 
context of sustained engagement. Importantly, we found that the sole variable that was 
consistently significantly related to AliveCor™ use, frequency of AF episodes, is also the only 
variable that was shared with patients via mHealth after being collected (compared to survey data 
that is not shared). Given the rapid increase in PGHD and mHealth technologies to capture 
PGHD, the possibility that viewing and understanding one’s own data is a motivating factor in 
sustaining self-monitoring warrants further investigation.
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Chapter Four: Factors Influencing Sustained Engagement with ECG Self-Monitoring: 
Perspectives from Patients and Healthcare Providers 
Chapter Four of this dissertation addresses the third aim by exploring individual patient 
differences in sustained engagement among adults with AF who are collecting and using PGHD, 
as well as potential approaches for improving sustained engagement. This manuscript is 
currently under review at Applied Clinical Informatics. 
Abstract 
Background: Patient-generated health data (PGHD) collected digitally with mobile health 
(mHealth) technology has garnered recent excitement for its potential to improve precision 
management of chronic conditions such as atrial fibrillation (AF), a common cardiac arrhythmia. 
However sustained engagement is a major barrier to collection of PGHD. Little is known about 
barriers to sustained engagement or strategies to intervene upon engagement through application 
design. 
Objectives: To investigate individual patient differences in sustained engagement among 
individuals with a history of AF who are self-monitoring using mHealth technology. 
Methods: This qualitative study involved patients, healthcare providers, and research 
coordinators previously involved in a randomized, controlled trial involving ECG self-
monitoring of AF. Patients were adults with a history of AF randomized to the intervention arm 
of this trial who self-monitored using ECG mHealth technology for six months. Semi-structured 
interviews and focus groups were conducted separately with healthcare providers and research 
coordinators, engaged patients, and unengaged patients. A validated model of sustained 
engagement, an adapted Unified Theory of Acceptance and Use of Technology (UTAUT), 
guided data collection and analysis through directed content analysis. 
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Results: We interviewed 13 patients (7 engaged, 6 unengaged), 6 healthcare providers, and 2 
research coordinators. In addition to finding differences between engaged and unengaged 
patients within each predictor in the adapted UTAUT model (perceived ease of use, perceived 
usefulness, facilitating conditions), four additional factors were identified as being related to 
sustained engagement in this population. These are: (1) personality/ behavioral tendencies, (2) 
relationship with healthcare provider, (3) supportive environments, and (4) feedback and 
guidance. 
Conclusions: Although it required some modification, the adapted UTAUT model was useful in 
improving understanding of the parameters of sustained engagement. The findings of this study 
provide options for the design of applications that engage patients in this unique population of 
adults with AF. 
Background and Significance 
An increasing number of patients are using mobile health (mHealth) technology, 
including smartphones and other connected devices, to generate data that provide a rich account 
of their day-to-day health (Bhavnani et al., 2016; NIH, 2015; Silva, Rodrigues, de la Torre Diez, 
Lopez-Coronado, & Saleem, 2015). These data, termed patient-generated health data (PGHD), 
may include physiologic measures, symptoms, and lifestyle data (Lai et al., 2017; Woods et al., 
2016). PGHD has garnered excitement for its ability to uncover fluctuations in health-related 
factors that may play an important role in an individual’s health and wellness (Arsoniadis et al., 
2015; Howie et al., 2014; Lavallee et al., 2016; Shapiro, Johnston, Wald, & Mon, 2012). PGHD 
also is valuable for centering care on the patient and their unique environmental, lifestyle, and 
biological circumstances (Lavallee et al., 2016; Sanger et al., 2016). As such, PGHD holds 
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particular promise for precision management of individuals living with chronic conditions 
(Antman & Loscalzo, 2016; Hull, 2015). 
One condition for which PGHD could be particularly valuable is atrial fibrillation (AF), 
the most common cardiac arrhythmia encountered in clinical practice (CDC, 2015). AF is 
difficult to capture outside the clinical setting because it requires documentation via 
electrocardiogram (ECG) and is poorly correlated with patient-reported symptoms (Kirchhof et 
al., 2017; Simantirakis et al., 2017; Verdino, 2015). Moreover, AF is deeply influenced by 
modifiable lifestyle factors such as alcohol use and obesity (Go et al., 2001; Huxley et al., 2011). 
Thus, PGHD can improve patient self-management of the arrhythmia, while also offering clinical 
benefits to providers seeking to improve detection and tailor care based on the unique 
characteristics of the patient (Olgun Kucuk et al., 2015; Turakhia & Kaiser, 2016). 
Sustained patient engagement with self-monitoring using mHealth technology is 
necessary to generate adequate health data to enable precision management (ONC, 2016). Yet 
evidence shows that patient engagement is low over time, with many patients abandoning self-
monitoring within three to six months of initiation (Glasgow et al., 2011; Mattila et al., 2013). 
There is a gap in understanding factors that contribute to sustained engagement, as much of the 
extant literature focuses solely on initial uptake of technology (Ford et al., 2015; Lasorsa et al., 
2016). Moreover, engagement research has had minimal success improving sustained 
engagement mainly using generic design tactics, such as gamification and incentives (e.g., 
points, money), that forgo consideration of unique patient characteristics (King et al., 2013; 
Shimada et al., 2016). 
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Objectives 
The purpose of this study was to investigate individual patient differences in sustained 
engagement among individuals with a history of AF who are self-monitoring using mHealth 
technology. Specifically, we aimed to uncover factors that are associated with sustained 
engagement in this unique patient population through qualitative focus groups and interviews 




Our investigation of sustained engagement was guided by the Unified Theory of 
Acceptance and Use of Technology (UTAUT) model (Venkatesh et al., 2003), which has been 
used in multiple health care studies (Kim, Lee, Hwang, & Yoo, 2016; Lin et al., 2016; Ma, Chan, 
& Chen, 2016). In our study we used a version of UTAUT that was adapted specifically for 
sustained engagement (Jiang et al., 2016). In the adapted model (Figure 4.1; see Figure 1.2 for 
full-size image), the predictors of sustained engagement with ECG mHealth technology are 
perceived ease of use, perceived usefulness, and three facilitating conditions tailored for our 
patient population: (1) AF knowledge, (2) severity of AF symptoms, and (3) frequency of AF 
episodes. Age and gender moderate the relationships between all predictors and the outcome, 
sustained engagement. Experience with technology moderates only the relationships of perceived 
ease of use and perceived usefulness with the outcome. 
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Figure 4.1. The adapted UTAUT model 
Study Design and Sample 
This qualitative descriptive study used focus groups and individual interviews with 
patients, healthcare providers (nurse practitioners and physicians), and research coordinators 
involved in the iPhone® Helping Evaluate Atrial Fibrillation Rhythm through Technology trial 
(iHEART; R01NR014853, PI: Hickey). This is an ongoing, five-year randomized, controlled 
trial of adults with a history of AF who have undergone a procedure to restore normal sinus 
rhythm to the heart (Hickey et al., 2016). They are randomized 1:1 to receive usual cardiac care 
of periodic electrocardiograms (ECGs) during office visits (control group) or usual cardiac care 
plus remote monitoring using the AliveCor™ device (intervention group). This device works 
with an accompanying smartphone application (app) to capture heart rate and rhythm via a 
single-lead ECG. Patients can use the app to document symptoms experienced during an ECG 
recording, or potential triggers of an AF episodes (e.g., exercise). iHEART intervention arm 
participants were asked to use the AliveCor™ device once daily for six months but had the 
option of continuing beyond this period. 
We recruited a convenience sample of iHEART intervention group participants who 
completed the trial within the past two months (to minimize recall bias). Healthcare providers 
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and research coordinators were recruited because of their potential for insights into patient 
engagement stemming from their close connection to patients during the trial. 
Recruitment and Data Collection 
After obtaining institutional review board approval, the primary author (M.R.) and the 
iHEART principal investigator (K.H.) identified potential participants and contacted them via 
telephone. Engaged patients, unengaged patients, and healthcare providers/research coordinators 
were recruited into separate sessions to facilitate candidness and comparison of engaged and 
unengaged patients. The level of engagement was determined by examining the HIPPA-
compliant, web-based AliveCor™ portal. We defined the engaged patient as one who used 
AliveCor™ at least once per day on average during the trial. We defined the unengaged patient 
as one who used the device less than once per day on average. 
Focus groups and interviews were conducted and analyzed until data saturation was 
reached. Each session lasted 30-60 minutes and was conducted in a private space at a large, 
urban academic medical center or over the phone when needed due to travel or scheduling 
reasons. The primary author moderated all sessions. A second researcher (K.T.H. or J.M.) was 
present for a subset of the sessions to ensure rigor in data collection. Participants received a $20 
Visa gift card for participation. Discussions were guided by interview/focus group guides 
developed to elicit understanding on each factor in the adapted UTAUT model (Appendix D). 
All focus groups and interviews were audio-recorded, transcribed verbatim, and spot-checked by 
the primary author (M.R.) for accuracy. 
Data Analysis 
The transcripts were analyzed by directed content analysis. This method uses factors 
from a relevant theory to guide data collection and analysis. Research/interview questions are 
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focused to allow rich exploration of the theory, but the technique does not preclude findings that 
may not fit the pre-selected theory (Graneheim & Lundman, 2004; Hsieh & Shannon, 2005). 
Following this approach, the primary author (M.R.) created a preliminary codebook of themes 
based on the factors described in the adapted UTAUT model, with separate sections for each 
participant group (engaged patients, unengaged patients, and providers/research coordinators). 
She then coded all transcripts to this codebook and separately reported new themes that emerged. 
Two additional analysts (D.B., M.B.) with no prior knowledge of the adapted UTAUT model 
independently coded two transcripts using open coding (e.g., no a priori codes) to verify that the 
emergent themes they identified were congruent with the preliminary codebook. The primary 
author then provided them with the preliminary codebook and they used directed coding to 
analyze three additional transcripts each, while identifying and separating themes that emerged 
outside of this codebook. 
At each stage, codes were compared and any discrepancies in coding were discussed and 
resolved. Inter-rater reliability was calculated to quantify coder agreement during directed 
coding, which was high (0.87-0.98). In addition, all analysts identified and reported on 
similarities and differences between participant groups because both variability and consistency 
in perspectives were considered valuable in advancing understanding of the theoretical model. 
All data was analyzed using NVivo 11 (QSR International, Inc., Burlington, MA). 
Results 
Description of the Sample and Overall Engagement 
We interviewed a total of 21 individuals: 13 patients (7 engaged, 6 unengaged); 6 
healthcare providers; and 2 research coordinators. We conducted 13 individual interviews:10 via 
phone with patients; 1 in-person with a patient; and 2 in-person with healthcare providers. We 
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also conducted two in-person focus groups: one with 2 unengaged patients; and one with 4 
healthcare providers and 2 research coordinators. 
Healthcare providers in this study included 4 nurse practitioners and 2 physicians. They 
had, on average, 22.7 years (range: 20-27) of clinical experience and 18.3 years (range: 13-25) 
working in the electrophysiology clinic from which iHEART participants were recruited. The 2 
iHEART research coordinators reported 3 and 25 years of clinical research experience 
respectively. 
Patients were predominantly male (85%) and middle- to older-age (mean 65.3 years, 
range 50-76), which reflects the demographics in the electrophysiology clinic from which they 
were recruited. Engaged and unengaged patients had approximately the same age and gender 
composition. Participants were asked a series of questions regarding their experience with 
technology at baseline in the iHEART trial. The patients in this study reported having experience 
with technology: all reported owning a cell phone and 78% owned a smartphone. All reported 
experience searching the Internet for health-related information, and all had a computer or tablet 
in their homes. 
Engaged patients used AliveCor™ 31.2 times per month for an average of 11.9 months, 
compared to 24.1 times per month and for an average of 9.3 months among unengaged patients. 
Figure 4.2 illustrates trajectories of AliveCor™ use over time, showing a clear difference in 
engagement between two groups despite a high level of engagement overall. Most engaged 
patients expressed intention to continue using the device indefinitely: “I’m still using it right 
now. And I’m planning to sign up to use it after the trial period…it’s a big help for me!”  –
Patient 3 (engaged). Conversely several unengaged participants used the device for shorter 
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periods of time: “I would take a guess it was three weeks, maybe four weeks.” –Patient 1 
(unengaged). 
Figure 4.2. Trajectories of engagement among iHEART participants interviewed in this study 
Factors Associated with Engagement in the adapted UTAUT Model 
First, we describe themes associated with sustained engagement found in the adapted 
UTAUT model. We then describe emergent themes not specified in the adapted UTAUT model. 
Illustrative quotes by theme and sub-theme are presented in Appendix E. 
Ease of Use. 
Similarities in Ease of Use. Both engaged and unengaged patients reported that the 
AliveCor™ device was easy to use with minimal, if any, learning curve. They reported that data 





































capture and sharing was simple with the device, and the lightweight design made it portable and 
therefore easy to capture ECGs quickly, easily, and virtually anywhere. Despite general ease of 
use, some technical challenges arose for most patients. The primary challenge they reported was 
difficulty transmitting an ECG due to poor connectivity between fingertips and the device, or the 
device and the application. This led to poor-quality readings and vague output from the rhythm-
identifying algorithm (e.g., “Unclassified”). Another problem they described was background 
noise interference when symptoms were recorded through voice-enabled technology. Healthcare 
providers and research coordinators also reported that patients experienced these technical issues. 
Differences in Responses to Technical Issues. The main difference between engaged 
and unengaged patients was in their attitude towards handling technical issues. All engaged 
patients reported on the strategies they used for dealing with challenges related to transmission 
and connectivity, such as moving away from other electronic devices or cleaning their fingers. 
Some stated that this helped them avoid becoming anxious. Conversely, many unengaged 
patients expressed frustration and anxiety as a result of technical issues, as one patient described: 
“I didn’t feel safe in my ability to get accurate readings.” –Patient 1 (unengaged). 
Differences in Healthcare Provider Feedback. Many engaged patients reported 
receiving a small yet adequate amount of guidance from healthcare providers, which allowed 
them to handle abnormal readings and vague algorithm output: “I did have several false 
readings…[the doctor] said don’t pay attention to those…He took that off the table for me to 
worry about.” –Patient 9 (engaged). Most unengaged patients, however, reported little to no 
feedback from healthcare providers to help them overcome these technical issues. In fact, many 
stated they were unsure if healthcare providers or study coordinators were even receiving their 
data. For some, this was the direct reason for abandoning the device, as one participant 
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explained: “I stopped because it said unclassified and…nothing was happening. And I was going 
insane. What was going on? I wanted feedback.” –Patient 11 (unengaged). All providers stated 
they acknowledged this need but also pointed to time being a limiting factor in their ability to 
provide constant feedback to patients. 
Usefulness of the Technology. 
Similarities in Usefulness of Identifying Rhythm. Most participants in both groups 
understood how difficult AF is to identify without an ECG. For this reason, they reported that 
AliveCor™ was useful in giving definitive rhythm identification, or “proof,” as one patient 
called it. As a result, most patients stated that these data had a comforting effect, which providers 
also reportedly recognized.  
Differences in Insights and Perceived Value of the Data. A major difference we found 
between engaged and unengaged patients was their ability to independently use the data they 
were collecting. Many engaged patients reported seeking further insights from the data beyond 
basic heart rhythm, and stated that the value of the data was a reason for sustained use: 
“Sometimes I'll forget to take the medication but I never forget [AliveCor™]… Because I value 
the feedback that it gives me tremendously.” –Patient 13 (engaged). Conversely many unengaged 
patients described confusion and difficulty interpreting their data: “When I stopped, I think part 
of it was getting the message unclassified kind of made wonder what the utility of this thing 
was.” –Patient 10 (unengaged). Even if confusion did not arise, some unengaged patients did not 
attach value to insights beyond rhythm identification: “I’m blissfully unaware of other stuff that I 
should want to know… I don’t know if there’s any other data that would be meaningful to me.” –
Patient 2 (unengaged). 
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Differences in Healthcare Provider Feedback. Many engaged patients reported sharing 
insights about their data (described as “the signals and symptoms” by one patient) with their 
healthcare providers to tailor their self-management and medical care.  Most providers 
recognized this as supporting the usefulness of the device: “We can try to sort out why they’re 
having this rhythm problem and identify any triggers.” –Provider 5. Most unengaged patients 
reported the need for interpretation to make the data useful, but expressed that they lacked 
adequate provider feedback. This led to anxiety and even distrust towards providers and 
researchers: “It seemed like a one-way street where you guys were just taking my information 
and I’m out there on my own.” –Patient 1 (unengaged).  All providers recognized a tendency for 
data to cause anxiety and distrust, and sometimes reportedly discouraged anxious patients from 
continuing to monitor as frequently: “I, in fact, encourage them to not check it as often– it just 
doesn’t serve any purpose besides potentially causing more anxiety about it.” –Provider 5. 
Facilitating Conditions. 
AF Severity: Long AF histories but varying proactive behaviors. Many patients in both 
groups reported living with AF for long periods of time but differed in how they reacted. Most 
engaged patients proactively changed behaviors, including healthier diets, abstaining from 
known AF “triggers” (e.g. drinking alcohol), and self-monitoring using AliveCor™ more 
frequently depending on clinical acuity: “I tried to use it every morning right after the 
ablation…As my rhythm returned to just a bunch of more normal kind of activity it became 
something I checked less.” –Patient 9 (engaged). In contrast many unengaged patients reported 
being easily discouraged by their AF recurrence, which they said caused them to self-monitor 
less and instead rely on office visits with providers for rhythm monitoring: “I’m no longer in AF, 
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at least, each time that I’ve been checked… I go in about every six weeks, just to be checked.” –
Patient 1 (unengaged). 
 Some providers observed that patients might appropriately decrease use over time if their 
heart rhythms became stable, indicating less AF severity: “It’s not that they lost interest. The 
issue is that for the clinical part… treatment is achieved and the patients are doing well…They’re 
not less engaged, they’re appropriately using it.” –Provider 1. They also pointed out, however, 
that this was only the case for patients who were truly clinically stable. If patients did not 
consider their clinical acuity, they could inappropriately discontinue use. 
AF Knowledge: Differences in Uncovering Self-knowledge. Most patients had high 
levels of knowledge about AF in general. In fact, healthcare providers described the participating 
patients as “very sophisticated and educated” (Provider 6). However patients’ knowledge of 
personal physiology and self-management needs (self-knowledge) varied. Approximately half of 
engaged patients stated that their self-knowledge improved through self-monitoring: “I think that 
what changed was my sense of how this problem was affecting my day to day life”–Patient 13 
(engaged). Most unengaged patients, however, relied on healthcare providers to understand their 
unique physiology and needs “[My doctor] had told me that relatively speaking [caffeine is] the 
least effective trigger for me. He said alcohol is the worst and it definitely is, there's no 
question.” –Patient 7 (unengaged). 
AF Symptoms: Driving Use for Unengaged Patients. The majority of the patients in 
both groups understood that poor correlation between AF symptoms and AF episodes (Barrett et 
al., 2014; Dekker et al., 2016; Simantirakis et al., 2017) was a reason to use AliveCor™ to 
identify their true cardiac rhythm. Many engaged patients appropriately considered their actual 
ECG data versus their symptoms in determining whether to continue using AliveCor™. 
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Conversely, for many unengaged patients, use was driven by symptoms. They interpreted lack of 
symptoms as a sign of wellness and a reason to stop using AliveCor™.  Alternatively, some 
patients experienced symptoms that they attributed to AF when they were in a normal rhythm, 
causing them to use AliveCor™ too frequently. One unengaged patient described how perceived 
symptoms caused anxiety: “I probably used it too much because every time I have chest pain, I 
just pull it out. And after a while, I just stop that…Because I can’t be doing it all the time.” –
Patient 5 (unengaged). Healthcare providers noticed this tendency: “They are not always in A fib 
when they do document symptoms… what they perceive to be something is not always the case.” 
–Research Coordinator 2. Most unengaged patients expressed more confusion about their
symptoms, describing them as unclear, inconsistently related to AF, and shifting over time. 
Moderators: Age, Gender, and Experience with Technology. Some healthcare 
providers and patients stated that they thought that age would influence ease of use and 
usefulness. Yet no patient described their own age as being an impediment to AliveCor™ use, 
and most providers expressed confidence in their patients’ ability to use the device regardless of 
age: “I’ve been surprised by how easily patients even in their 60’s, 70’s and 80’s have adopted 
using this.” –Provider 6. Similarly, both engaged and unengaged patients described comfort with 
technology, and many even reported tracking other aspects of their health with wearable devices 
and mobile applications. Even patients who did not consider themselves ‘tech savvy’ expressed 
comfort using AliveCor™, commenting on its simple design: “I picked it up very easily. It was 
simple. And I’m not very good—I can’t even program a remote control.” –Patient 5 
(unengaged). Healthcare providers and research coordinators agreed that tech savvy was 
unimportant if patients’ “enthusiasm for their care is there” -Research Coordinator 1. Unlike 
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these other moderating factors, no participant explicitly discussed gender in the context of 
engagement with technology. 
New Findings 
Personality traits and behavioral tendencies. Common patient personality traits and 
behaviors emerged during the analysis. Most patients in both groups expressed as a sense of 
concern about their health. All considered themselves a part of the collaborative disease 
management process: “I’d like to live a long healthy life and being 50 years old, it’s time to 
make a change. I'm hoping…I can continue to have a quality of life as I grow older.” –Patient 4 
(engaged). However, concern for one’s health tended to escalate to anxiety for many unengaged 
patients, which healthcare providers corroborated: “Once they see something unusual from the 
baseline…they panic…they call right away.” –Provider 1. 
Relationship with Healthcare Provider. Most engaged patients described positive 
working relationships with their healthcare providers. They stated that either they had a strong 
relationship prior to using AliveCor™, or the device and the data it generated improved the 
collaborative relationship between the patient and the providers. One patient said: “With the 
AliveCor™ device at Columbia, I feel like I am, you know, 99% in tune with them, or they with 
me, because it just gives them such important information.” –Patient 6 (engaged). Some engaged 
patients also stated that the device improved collaboration between members of their care team. 
Unengaged patients more frequently described relationships with providers that were less 
collaborative and more patriarchal. They described skepticism and a need to advocate for 
themselves: “I wish they would listen to me. I don’t think they have any idea what to do with me. 
They’re not looking at the whole picture.” –Patient 5 (unengaged). 
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Creating Supportive Environments. Both engaged and unengaged patients described 
routines and reminders to integrate self-monitoring into daily habits. Many kept the device in the 
same place as a physical cue to make self-monitoring with AliveCor™ part of their “daily 
ritual,” as one patient called it. Others took the device with them to spot-check if they 
experienced symptoms. 
However all engaged participants reported they maintained these environments, even 
when busy or travelling: “If I've missed the night I know to do it early in the morning and then 
just do twice the next day. It’s rare…If I'm traveling I’ll take it with me.” –Patient 8 (engaged). 
Moreover, most engaged patients, as well as healthcare providers, described supportive networks 
of friends and family as being critical in sustaining engagement with technical support and 
reminders: “Remembering was difficult but my wife was very helpful in the evenings and in the 
mornings.” – Patient 13 (engaged). Alternatively, most unengaged participants described busy 
schedules and travelling as interfering with use: “On weekends I didn't do it…from the 
beginning I wasn't doing it every day. I guess, I just forgot it. I don’t take it to work.” –Patient 11 
(unengaged). Few discussed support from family members, friends, or providers to help them to 
use the device regularly. 
Discussion 
Summary of Findings 
In this study we found similarities and differences between engaged and unengaged 
patients who used AliveCor™ mHealth ECG technology to self-monitor their AF, which were 
corroborated by their healthcare providers and research coordinators. All patients described the 
technology as easy to use and useful on a basic level. All had long AF histories and high AF 
knowledge, including about the poor correlation between AF episodes and AF symptoms. 
Nonetheless, distinct and nuanced patterns emerged that distinguished engaged patients from 
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unengaged patients. Unengaged patients were generally frustrated by technical issues and 
confused by their heart rhythm data. Most lacked a supportive environment and strong 
relationships with their healthcare providers to help mitigate these issues, and their concern for 
their health tended to escalate into anxiety, causing abandonment. Their clinical characteristics, 
such as their long AF histories, AF symptoms, and knowledge of their unique physiologies (self-
knowledge), were also related to their low sustained engagement. Conversely, most engaged 
patients were uninhibited by technical issues and able to interpret their data on deeper levels. 
They described supportive environments that promoted engagement, including reminders and 
habits, social support, and strong relationships with healthcare providers. They viewed self-
monitoring as important in addressing their long AF histories, regardless of their perception of 
symptoms, and reported the data they collected increased their self-knowledge. 
Fit With the Adapted UTAUT Model 
This study found that the adapted UTAUT model adequately describes predictors of 
sustained engagement in this population. We found differences in the hypothesized predictors of 
sustained engagement (ease of use, usefulness, and the three facilitating conditions: severity of 
AF symptoms, AF knowledge, frequency of AF episodes) between engaged and unengaged 
patients. For our population, the hypothesized moderators (age, gender, and experience with 
technology) appeared less influential in the relationship between predictors and sustained 
engagement than we anticipated. This could be a reflection of a lack of variability within the 
study sample, as survey data indicated that participants were similar in age and experience with 
technology, and were predominantly male. 
Our findings suggest that four additional factors may contribute to sustained engagement 
in this population. Three of the four appear to operate as facilitating conditions. First, patients’ 
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personalities and behavioral tendencies, particularly concern about health, were either a 
motivating force (as they were for engaged patients), or a mitigating force when concern 
escalated into anxiety (for some unengaged patients). Second, supportive environments, when 
present, fostered sustained engagement. A lack of such an environment was described as a reason 
for non-use among unengaged patients. Third, patients’ relationships with their healthcare 
providers, which ranged from collaborative (engaged patients) to deferential (unengaged 
patients), influenced sustained engagement. The fourth factor, feedback from healthcare 
providers, was discussed in the context of both perceived ease of use and perceived usefulness, 
and thus may have a moderating effect on these predictors. Specifically, unengaged patients 
wanted healthcare providers’ feedback to mitigate technical issues and improve understanding of 
data, and stated that a lack of feedback was a primary reason for non-use. 
The original, unadapted UTAUT model contained factors that were condensed or 
eliminated in the adapted UTAUT model upon which we based our study (Jiang et al., 2016). 
Three of the four additional factors that emerged in this study align with those eliminated from 
the original UTAUT model. Specifically, individuals’ internal values and supportive 
environments are two facilitating conditions in the original UTAUT model. “Social influence” is 
also present in the unadapted UTAUT model, which broadly aligns with the patient-provider 
relationship factor that we identified (Venkatesh et al., 2003). 
Relationship to Prior Work 
To our knowledge this is the first study to use qualitative, primary source data to generate 
a comprehensive list of factors related to sustained engagement with mHealth in a specific 
patient population. Jiang et al. (2016) first used an adapted UTAUT model to predict sustained 
engagement among lung transplant patients. We extend their work by validating the utility of the 
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adapted model in a different patient population and, by doing so, identified additional factors 
relevant to sustained engagement. 
Recent studies that examined sustained engagement using quantitative methods (such as 
surveys) have not captured nuanced influences on engagement. For instance, technology-related 
factors such as perceived ease of use and perceived usefulness have previously been identified as 
important correlates of sustained engagement (Hermsen et al., 2017; Sharpe et al., 2017). Our 
qualitative study uncovered subtle differences between engaged and unengaged patients, such as 
the depth of their insights from the data or their ability to troubleshoot technical issues. Another 
study found evidence that internal motivation, a construct from self-determination theory, is 
critical for sustained engagement (Coa & Patrick, 2016). While this aligns with our finding that 
concern for one’s health was an internal motivator for all our patient subjects, some became 
frustrated or confused by self-monitoring, and the resulting anxiety dampened their engagement 
over time. The relationship between internal motivation and sustained engagement therefore 
warrants future research in different populations in which internal motivation may be more 
variable. 
Implications for Design 
An understanding of factors related to sustained engagement may be useful in tailoring 
design of self-monitoring applications. Table 4.1 maps these factors to specific design 
implications, which include two major approaches. A first set of approaches focuses on feedback 
that unengaged patients reportedly lacked. These include links to online communities that might 
facilitate patient-to-patient communication, or application-based messaging with healthcare 
providers that might improve patient-provider communication and overall relationship. This is a 
controversial option, however, given the well-documented time, liability, reimbursement, and 
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scope of practice issues that providers cite in response to application-based messaging (M. J. 
Reading & Merrill, 2018). 
A second set of approaches focuses on automation to satisfy needs described by patients. 
These include tested solutions that have yet to be implemented for self-monitoring. For instance, 
clinical decision support, previously developed to support healthcare providers (Beeler, Bates, & 
Hug, 2014; O'Sullivan, Fraccaro, Carson, & Weller, 2014), could guide patients’ interpretation 
and evaluation of their own clinical presentation through the data. Infobuttons, which are widely 
used in electronic health records (EHRs), merit application to mobile health applications (Long, 
Hulse, & Tao, 2015; Teixeira, Cook, Heale, & Del Fiol, 2017). Interactive visualizations that 
help individuals make sense of large amounts of complex data, have potential applications to 
patient-generated health data (Gotz & Borland, 2016; Woods et al., 2016).
In this study all subjects, including providers and research coordinators, noted that the 
feature for recording symptoms and triggers within Alivecor™ was difficult to use. However the 
relationship between AF symptoms, episodes, and triggers varies by individual (Barrett et al., 
2014). If application design eases capture of AF symptoms and triggers, those data points could 
be triangulated with ECG data to discover manifestations of AF unique to the individual. 
Visualizations developed to enhance understanding of these triangulated data could improve AF 
management (Gotz & Borland, 2016). 
94 





























✓ ✓ ✓ 
AF 
Symptoms* 
















Implications for Research 
Our findings suggest a number of new lines of inquiry regarding sustained engagement. 
Healthcare providers observed there is a time to appropriately stop self-monitoring (if clinically 
stable for an extended period of time). For what length of time do patients actually need to self-
monitor to receive a clinical benefit for specific conditions? Previous work has identified exact 
durations of remote monitoring necessary to diagnose or manage arrhythmias with implantable 
cardiac devices (Cheung, Kerr, & Krahn, 2014; Tung, Su, Turakhia, & Lansberg, 2014; Turakhia 
et al., 2013), but overall this issue is inadequately studied in the self-monitoring space. While we 
have identified a number of application design features that can target engagement, there remains 
the larger philosophical question of whether sustained engagement should be the goal for each 
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patient. Patients and healthcare providers alike noted that anxiety could overcome utility for 
some patients. Others have found similar negative emotional responses to self-monitoring 
(Ancker et al., 2015; Purtzer & Hermansen-Kobulnicky, 2016). While thoughtful design of 
applications that improve communication and information regarding the data may help, it will 
not mitigate anxiety for all patients. In such cases, the risk of continued anxiety, which itself is a 
risk factor for AF recurrence, may outweigh any clinical benefit of self-monitoring for the 
patient. 
Limitations 
This study had some limitations. First, while we attempted to classify patients’ 
engagement from their behavior recorded in the AliveCor™ portal, more precise classification of 
engagement was not possible because raw usage data was not available. We may have 
inadvertently misclassified some patients’ engagement. Second, this patient population was 
uniquely well educated regarding their arrhythmia and highly engaged in their care overall. They 
were also predominantly male, middle- to older-age, and moderately to extremely comfortable 
with technology. Our sample therefore had little variability and tended towards high engagement 
with self-monitoring. While we made every attempt during our analysis to bracket biases that 
resulted from these sample characteristics, our findings are likely not generalizable to other 
patient populations. We have demonstrated that theoretical models guiding data analysis always 
need to consider the unique patient population being studied. 
Conclusion 
This study provides insights on factors related to sustained engagement in a unique 
population of adults living with AF. We found evidence that the UTAUT model can serve as a 
valid framework for understanding sustained engagement, though it requires modifications to 
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account for the patient population in consideration. The theory-driven findings we elicited can 
guide design and development of mobile application interfaces for self-monitoring to engage 
adults living with AF for a sustained period of time. The UTAUT model also may guide 
establishment of parameters for sustained engagement for different patient populations in future 
work. Theory-based evidence for application design may be useful in facilitating potential health 
benefits of PGHD collected with mHealth technology. 
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Chapter Five: Conclusions 
This dissertation aims to examine patients’ and providers’ collection and use of digital 
patient-generated health data (PGHD) in real-world settings, which includes their expressed 
needs and possible approaches to meeting these needs. This dissertation is composed of Chapter 
Two, an integrative review examining convergent and divergent areas of need for collecting and 
using patient-generated health data (PGHD) identified by patients and healthcare providers; 
Chapter Three, a quantitative study evaluating predictors and moderators of sustained 
engagement in a post-intervention population of adults self-monitoring their AF; and Chapter 
Four, a qualitative study exploring the utility of the adapted UTAUT model in characterizing 
sustained engagement in this unique patient population. In Chapter Five, key findings from each 
of the preceding chapters are summarized and discussed in the context of related work. We then 
elicit implications for the intersection of health policy and clinical practice, design, nursing, and 
future research from our findings. 
Summary of Results and Key Findings 
Chapter Two 
Chapter Two consists of an integrative review that examined convergent and divergent 
needs when collecting and using patient-generated health data (PGHD) identified by patients and 
providers (i.e. physicians, nurses, advanced practice nurses, physician assistants, and dietitians). 
By synthesizing findings from eleven studies (seven mixed-methods, four qualitative), we found 
that patients and providers converged on clinical and technological needs and diverged on 
logistic needs. We also found evidence of interplay between patients’ and providers’ needs. 
Patients need feedback and reassurance, and providers need to manage the flow of PGHD in their 
clinical practice. 
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This review compiles a detailed description of patients’ and providers’ needs that may 
serve as the basis for an initial set of requirement specifications for systems that collect and 
display PGHD in future work. Recently, ONC published a practical guide for providers and 
researchers seeking to use PGHD (ONC, January 2018a). This guide provides high-level 
considerations for engaging patients to collect these data, and integrating these data into clinical 
workflows from a technical, functional, and financial perspective. The findings of our integrative 
review of primary source data from important stakeholders (patients and providers) supplement 
ONC’s guide with more detailed considerations for addressing stakeholders’ concerns. 
Importantly, in an updated white paper on PGHD, ONC acknowledged continued reticence to 
adopt PGHD among patients and providers due to ongoing concerns about unmet needs (ONC, 
January 2018b). In fact, CMS recently proposed removing the integration of PGHD into the EHR 
from its quality measures due to providers’ reports that this criteria was too burdensome, which 
we discuss in more detail below (CMS, 2018a). The findings of our review may provide timely 
recommendations to allay patients’ and providers’ concerns about PGHD. 
Chapters Three and Four 
The studies in Chapters Three and Four are discussed together because they offer 
complementary perspectives on sustained engagement. Areas of alignment between each study 
substantiate parts of the adapted UTAUT model (Figure 5.1; see Figure 2.1 for full-size image), 
while discordant findings indicate areas for further exploration. The triangulation and integration 
of findings from these quantitative and qualitative studies offers a more complete understanding 
of the results (Scott, 2016). 
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Figure 5.1. The Adapted UTAUT Model 
Patient sustained engagement with self-monitoring is studied in detail in the studies 
described in Chapters Three and Four as a major barrier to PGHD collection. Chapter Three 
consists of a quantitative evaluation of the adapted UTAUT model among adults who are self-
monitoring AF in the context of the iHEART trial using Hierarchical Generalized Linear 
Modeling (HGLM). Chapter Four explores the adapted UTAUT model more deeply through 
qualitative investigation using directed content analysis of focus groups and interviews with 
patients, providers, and research coordinators in the iHEART trial. The quantitative study 
provided preliminary evidence that some of the predictors (frequency of AF episodes, AF 
knowledge, and perceived usefulness) in the adapted UTAUT model are related to sustained 
engagement. The qualitative study found support for all of the predictors with nuanced 
explanations for differences between engaged and unengaged patients. We also identified four 
additional factors in the qualitative study: (1) personality/ behavioral tendencies, (2) relationship 
with healthcare provider, (3) supportive environments, and (4) feedback and guidance. 
Neither study found evidence of moderating effects of age, gender, or experience with 
technology on the relationship between predictors and sustained engagement. This may reflect 
the underlying lack of variability in the iHEART trial subjects, who were similar in these 
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respects. Alternatively, demographic characteristics typically associated with technology use 
may be less relevant as mobile technology becomes ubiquitous in society across age, gender, 
race/ethnicity, socioeconomic, and geographic groups (Pew, 2018). Assumptions surrounding 
technology adoption and use may need to be revisited given the degree to which technology has 
permeated all aspects of society since the UTAUT model was constructed by Venkatesh et al. in 
2003. 
Recent studies have identified individual predictors of sustained engagement, including 
perceived ease of use, perceived usefulness, age, gender, and health-related characteristics 
(Hermsen et al., 2017; Park et al., 2018; Sharpe et al., 2017). However to our knowledge, only 
Jiang et al. (2016) have sought to validate a theoretical model (an adapted version of the UTAUT 
model) that can be broadly applied for future sustained engagement research. By using the 
adapted UTAUT model, we were able to understand the parameters of sustained engagement 
among adults with AF who are unique from individuals with other chronic conditions, as others 
have reported about adults with AF (Dagres et al., 2007; Kaiser et al., 2016; Lip et al., 2015). 
The adapted UTAUT model used in this dissertation was based on the work of Jiang et al. 
(2016), who condensed some aspects of the original UTAUT model when they adapted it for 
sustained engagement. However, we found evidence that, in our patient population, some factors 
present in the original UTAUT model (individuals’ internal values and supportive environments 
as two additional facilitating conditions, “social influence” as an additional predictor) were 
related to sustained engagement. This led us to conclude that the UTAUT model always needs to 
be modified to the unique characteristics of a patient population. 
Based on the findings of this dissertation, those seeking to adapt UTAUT to other 
populations should consult relevant clinical literature to identify any documented relationships 
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between variables in the UTAUT model (such as age, gender, and disease-specific 
characteristics) that may interact to influence sustained engagement together. In addition, both 
quantitative and qualitative methods are useful, as we were able to uncover nuances and 
additional factors associated with sustained engagement through qualitative interviews and focus 
groups that were not identifiable through quantitative analysis. Importantly, more accurate 
measurement of constructs from the adapted UTAUT model at the time of the most reliable data, 
which is likely at the time of mHealth use, should be explored due to limitations of secondary 
data analysis discussed in Chapter Three. Real-time data capture via smartphone application, 
such as ecological momentary assessment (EMA), is one feasible approach as smartphones 
become increasingly popular and prevalent (Pew, 2018). Through this approach, individuals’ 
responses to questions of interest may have higher content validity and fewer limitations 
(missing data, recall bias) to allow for a more robust evaluation of the adapted UTAUT model in 
the context of sustained engagement (Hand & Perzynski, 2016; Shiffman et al., 2008). 
Themes from the Findings of this Dissertation 
Shift towards a collaborative patient-centered model. In recent decades, the model of 
patient care has shifted from one in which patients are deferential and providers have authority, 
towards one in which patients are considered active and valued members of the care team 
(Knorr-Cetina, 2003). In Chapter Two we found that patients and providers report that PGHD 
enhances the working patient-provider relationship by fostering communication and information 
exchange. In Chapter Four, our subjects reported that a collaborative patient-provider 
relationship could sustain patient engagement to collect PGHD. Others have anticipated that 
PGHD will be a major component of the paradigm shift towards collaborative, patient-centered 
healthcare (Hull, 2015; Van Doornik, 2013) and the findings of this dissertation provide early 
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evidence of that. At the same time, we also found that in most systems for collecting and using 
PGHD described in Chapter Two, only providers and not patients were the intended audience of 
PGHD. Therefore, our design implications (discussed later) recognize that the patient is an 
increasingly vital part of the care team and thus, consider the patient a user, not only a collector, 
of PGHD. 
The importance of considering patients and providers together. By examining 
patients’ and providers’ perspectives together in Chapters Two and Four, we found inextricable 
links between these two stakeholders in the process of collecting and using PGHD. For instance, 
patients needed feedback and guidance from providers, while providers needed to set boundaries 
with patients to manage the flow of data into their practice. Each group was also aware of each 
other’s needs even if it did not relate to their own, such as when providers acknowledged that 
patients need support regarding data collection to avoid becoming anxious. This suggests that 
systems that collect and display PGHD should be developed with both primary stakeholders in 
mind. While this approach may present challenges regarding the detail and complexity of data 
display, it has the potential to enhance transparency and mitigate many of the challenges 
described by patients and providers regarding communication and interoperability (Lavallee et 
al., 2016). 
Revisiting the concept of engagement. By examining individual factors that contribute 
to sustained engagement, we conclude that it is a multifaceted concept. This dissertation 
uncovered three interconnected facets contributing sustained engagement with self-monitoring: 
the patient, the provider, and the technology. This conceptualization helps to explain why 
research that addressed these facets in isolation has demonstrated little success improving 
sustained engagement (King et al., 2013; Shimada, Allison, Rosen, Feng, & Houston, 2016). 
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Further, our findings suggest that all three facets should be incorporated into the design and 
evaluation of self-monitoring technologies that facilitate sustained engagement. 
In this dissertation we found evidence that engagement is more complex than use or non-
use of mHealth technology. For instance, those patients who appropriately discontinue self-
monitoring when clinically stable may be less frequent users over time, but their independent 
interpretation of their self-monitoring data would deem them engaged in their overall self-
management. However, there exists a lack of a clear definition of engagement with self-
monitoring in the informatics community. Moreover, while usage may not be a measure of 
engagement that fully captures its dimensionality, usage data is the most common approach to 
understanding engagement in the absence of a standardized measurement of the phenomenon. 
Future work should seek to develop a standardized definition and measurement of engagement 
with self-monitoring that still accounts for nuances such as those described above. 
Leveraging PGHD to sustain patient engagement. The findings of this dissertation 
highlight new opportunities to use PGHD to motivate this unique group of patients with AF to 
continue to collect PGHD. Specifically, we found that adults with AF who derive value from 
their self-monitoring data continue to collect it. They reportedly derive value from understanding 
their health data in the context of their personal as well as population norms, and from 
understanding the impact of their lifestyle and other behaviors on their health (quantified with 
PGHD). Similarly, ONC’s practical guide states that highlighting the personal value of PGHD 
can be a tool for motivating individuals to continue to collect it (ONC, January 2018a). However, 
the possibility of using PGHD to motivate further data collection has been primarily explored 
among patients who are highly activated to collect these data in the first place, such as members 
of the “Quantified Self” movement, but is not well understood among patients for whom baseline 
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engagement is more variable (Braber, 2016; Miyamoto et al., 2016). Therefore, individuals who 
are not intrinsically motivated by their own data require a tailored approach to engagement based 
on their distinct motivations. 
Limitations and Strengths 
This dissertation has several limitations. The integrative review in Chapter Two is 
comprised of a heterogeneous sample of studies with respect to clinical focus, samples of 
subjects, and type and purpose of PGHD collected. This made generalization of findings across 
studies included in the review difficult. At the same time, the studies in Chapters Three and Four 
are limited by using data and participants from the ongoing iHEART trial, who were highly 
similar to one another and unique from other patient populations. This is especially true of the 
patients described in Chapter Four, who self-selected to participate in focus groups and 
interviews and are likely among the most engaged iHEART participants. Therefore, the results of 
these studies reflect a patient population that is not generalizable to others with chronic 
conditions. Additionally, the small number of subjects and use of secondary data that was prone 
to missing values and recall bias limited the quantitative study in Chapter Three. 
Nonetheless, this dissertation has clear strengths. The study in Chapter Two contributes a 
synthesis of rich accounts of PGHD use in real-world settings from two primary stakeholders, 
patients and providers, to the literature. From these accounts we compiled a list of diverging and 
converging needs, which may inform future design of systems involving PGHD collection and 
use that accommodate the needs of both major stakeholders. The design of such systems is 
needed given major aligning initiatives to accelerate the integration of PGHD into clinical 
practice (CMS, 2017b; ONC, January 2018b). We also conducted a more thorough investigation 
of one barrier to PGHD collection in particular, sustained engagement, that has been well 
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documented but not thoroughly explored (Hermsen et al., 2017; Lai et al., 2017). Using a 
validated model of sustained engagement allowed us to clarify the parameters of sustained 
engagement in a unique patient population of adults with AF, and use these parameters to 
generate design options for engaging adults with AF to collect PGHD for a sustained period of 
time. These studies are also strengthened by the use of application usage data from patients self-
monitoring in their daily lives over one year. This allowed for examination of more natural 
patient behaviors that are difficult to observe in health sciences research, in which app use is 
typically studied for shorter periods of time and in more controlled settings (Lai et al., 2017). 
Additionally, by interviewing a variety of stakeholders, including patients (engaged and 
unengaged), healthcare providers, and research coordinators, our understanding of sustained 
engagement in this population is multifaceted and the design options for optimizing patient 
sustained engagement are likely more comprehensive. 
Implications 
Implications at the Intersection of Clinical Practice and Health Policy 
Much of healthcare reform stemming from the Affordable Care Act (ACA) and 
associated legislation, such as HITECH, MACRA, and 21st Century Cures, has emphasized and 
promoted health information technology (HIT) to support a transformed system ("21st Century 
Cures Act (Cures Act) ", 2016; "The Health Information Technology for Economic and Clinical 
Health (HITECH) Act," 2009; "Medicare Access and CHIP Reauthorization Act of 2015," 2015; 
"Patient Protection and Affordable Care Act," 2010). Each of these pieces of legislation contain 
significant provisions that have supported the development and adoption of HIT over the past 
eight years, creating an impetus for this technology in clinical practice through incentives, 
mandates, and laws (Van Doornik, 2013). Moreover these changes are occurring quickly, with 
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new policy related to PGHD having been proposed or passed even since the initial conception of 
this dissertation (CMS, 2017b, 2018a). Therefore we focus on the implications of our findings at 
the intersection of clinical practice and health policy, rather than considering each in isolation. 
PGHD is poised to dramatically alter clinical practice in years to come (ONC, January 
2018b). The findings of this dissertation support previous research reporting that PGHD 
produces information and knowledge to support clinical decision-making for providers, and also 
provides a context for those decisions (C. F. Chung et al., 2016; Shaw et al., 2015). In this way 
PGHD represents an opportunity to personalize care based on the unique characteristics of 
individual patients. By aggregating data from individuals to understand population-level 
relationships between determinants of health and health outcomes, PGHD also has the potential 
to improve population health (Bauer et al., 2014). PGHD may be especially beneficial for 
individuals and populations in the setting of chronic conditions, whose trajectory is influenced by 
the synergy of biology, environment, and lifestyle (Bell, 2017). 
Policy initiatives surrounding PGHD continue to provide momentum for these data to be 
collected and used by healthcare providers and health sciences researchers. Recognizing PGHD 
as having the potential to advance patient engagement, care delivery, and research, ONC 
continues to support the integration of PGHD into the EHR (HealthIT.gov, 2016). The quality 
payment program initiated by MACRA includes a Merit-based Incentive Payment System 
(MIPS), which measures clinicians’ performance based on quality measures (CMS, 2018c). 
Incorporation of PGHD into a certified EHR for at least one patient is a quality measure that 
advances care information through coordination of care and patient engagement (CMS, 2018b). 
Recently proposed changes would remove mandatory reporting on this measure due to the 
burden to providers (CMS, 2018a), and the informatics community will need to address the 
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complexity and burden of PGHD for providers in clinical practice. Nonetheless, CMS will 
continue to reimburse providers for the review of certain PGHD under the 2018 Physician Fee 
Schedule, which incentivizes integration of these data into clinical care (CMS, 2017). 
In addition, the National Academy of Medicine (formerly the Institute of Medicine) has 
promoted the concept of the Learning Healthcare System, in which new knowledge is captured 
and integrated into the care delivery system in a seamless, cyclical process to support continuous 
improvement and innovation ("Background: Learning Healthcare System," 2018). PGHD has 
been acknowledged as an important source of information from outside of the clinical setting to 
be incorporated into the Learning Healthcare System (Foley & Fairmichael, 2015). Finally, 
funding and opportunities related to the Precision Medicine Initiative, including the National 
Institute of Health’s “All of Us” Research Program, have been growing and include the use of 
PGHD to understand relationships between lifestyle, environment, and biology (NIH, 2018). 
Although evidence demonstrating the health and cost benefits of PGHD is growing, it 
remains limited and inconclusive, which has hampered clinical adoption and research activity 
related to implemented PGHD use in real-world settings (Bloss et al., 2016; ONC, January 
2018b). In fact, one recent review article found a growing number of pilot studies using mHealth 
to collect PGHD, but a lack of research on the use of these data by patients and providers (Lai et 
al., 2017). Providers and researchers will need to collaborative and capitalize on the aligning 
policy initiatives described above to generate an evidence base of best practices related to PGHD 
(ONC, January 2018b; Tiase, 2017). 
Evidence on PGHD use in real-world settings will clarify its potential to improve patient-
provider communication and proactively manage health, especially chronic conditions, which are 
the most common and costly health conditions in the U.S. (Buttorff, 2017; CDC, 2016). 
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Ultimately, the vision is that PGHD will improve the quality of both individual and population 
health, as well as the patient experience, while reducing costs (C. F. Chung et al., 2016; Hsueh, 
Dey, Das, & Wetter, 2017; Van Doornik, 2013). The Quadruple (formerly Triple) Aim of better 
care, better health, lower cost, and now provider satisfaction continues to drive the evolution of 
our healthcare system (Bodenheimer & Sinsky, 2014). Though PGHD may be instrumental to 
achieving the Quadruple Aim, the findings of this dissertation research highlight the need for 
rigorous implementation research to ensure PGHD is a catalyst, not a detriment, to these goals. 
Implications for Design 
Table 5.1 provides a summary of existing mHealth design options and system 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































These design options are comprised of existing informatics tools that have yet to be 
widely implemented for self-monitoring. Although we studied different patient and provider 
populations in the integrative review and in the iHEART trial, design implications were 
congruent across studies and with recommendations recently published by ONC (ONC, January 
2018a). These design options are meant to be studied, adapted, and iterated upon based on the 
unique characteristics of other patient and provider populations. 
While we offer options that focus on design as a means of addressing many of the needs 
expressed by patients and providers in this dissertation, some of the needs that center on 
workflow, reimbursement, time, and communication are best addressed through other 
approaches, such as health policy, institutional protocols, and face-to-face patient-provider 
communication. In fact, some of the solutions we propose rest on the assumption that these other 
approaches are also instituted, and that design is merely a reinforcing factor. Nonetheless, while 
policy and initiatives surrounding PGHD are, to a certain extent, out of the purview of 
researchers, design is a research-based approach for meeting the needs of patients and providers 
that is less contingent on political and social undercurrents. 
Design and development of mHealth technologies that aim to address expressed needs of 
patients and providers regarding PGHD must also consider the changing role of the Food and 
Drug Administration (FDA) in regulating these technologies. The 21st Century Cures Act 
clarified the FDA’s role in regulating digital health by amending the definition of “device” to 
clarify software functions that were included and excluded from its regulatory scope ("21st 
Century Cures Act (Cures Act) ", 2016). In response, the FDA published a series of guidance 
papers outlining changes to their policies and procedures as a result of the Cures Act. These 
include papers specifically addressing: (1) low risk general wellness products (e.g., weight 
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management and physical fitness tracking), (2) clinical and patient decision support, (3) medical 
devices, (4) medical software, and (5) Software as a Medical Device (SaMD) (FDA, 2018). 
Not only will researchers seeking to design and develop mHealth have to comply with the 
FDA’s evolving regulations, but they will also need to consider the safety implications of 
releasing technologies for use by patients and providers that are not regulated. Without 
thoughtful design, patients and providers may draw inaccurate conclusions from digital health 
data and take inappropriate, possibly unsafe actions as a result of these conclusions (Howie et al., 
2014). 
Implications for Nursing 
As the providers on the front-line of patient care, nurses and advanced practice nurses are 
likely to be among those most affected by the deluge of PGHD into clinical practice (Hull, 
2015). As a tool for patient empowerment allowing patients to proactively manage their health, 
PGHD aligns with the nurse’s role of delivering patient-centered care and empowering the 
patient (Samples, Ni, & Shaw, 2014). Therefore, nurses will be in a position to voice not only 
their perspective, but also the perspective of their patients (Hull, 2015; Tiase, 2017). These 
voices are critical in the current environment in which systems that collect and display PGHD 
are now being designed, developed, and used in clinical practice and research. 
In addition, nurses and nursing informatics researchers are uniquely positioned to develop 
data science approaches for creating meaning from PGHD, including visualizations. Nursing 
informatics research focuses on leading the development, design, and implementation of 
technologies for presenting and retrieving information to support patients, nurses, and other 
providers (AMIA, 2009; Gee et al., 2012). With regards to PGHD, key questions for nursing 
informatics research will include how PGHD can be optimally integrated into nursing practice 
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such that it can inform nursing knowledge, support shared decision-making, and improve nursing 
care of individuals and populations (Hull, 2015). Nurses and advanced practice nurses in clinical 
practice can provide insights on optimal use of these data that consider both patients’ and 
providers’ priorities and realities. This can inform the iterative development of visualizations and 
other techniques to support use of PGHD. 
However, nurses remain underprepared to practice and collaborate with researchers in an 
increasingly technological clinical environment. A recent study demonstrated that nurse 
executives lack competency-based nursing informatics education and training, and are unaware 
of the competencies they should expect in their nursing graduates (Collins, Yen, Phillips, & 
Kennedy, 2017). At the same time, nursing graduates continued to be underprepared for 
informatics tools and concepts they will encounter in clinical practice because precise 
informatics competencies have yet to be well integrated into nursing curricula (Foster & 
Sethares, 2017). As new forms of data and technology increasingly pervade clinical practice, all 
clinical nurses, not just nursing informatics specialists (as was the case in years past), will need 
to be equipped with informatics training. With informatics training, nurses will gain awareness 
of how their knowledge of their nursing practice and of the patient can both inform and benefit 
from technology development (Foster & Sethares, 2017). The anticipated surge in PGHD in the 
near future places more urgency on the necessity that all nurses understand the informatics 
aspects of PGHD to ensure they are collected, managed, and presented appropriately (Hull, 2015; 
Tiase, 2017). 
Moreover, in this dissertation, we found that the nurse’s role and scope of practice 
relating to PGHD remain poorly defined, even in those settings that are more accustomed to 
receiving PGHD than most, such as electrophysiology (Turakhia & Kaiser, 2016). Nurses and 
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nurse practitioners are unsure how their current clinical practice will translate to reviewing and 
responding to PGHD. For instance, can they independently titrate patients’ medications based on 
these data? Can they make diagnoses with it? As the role of nurses in the integrated care team 
evolves, the unique responsibilities and priorities of nursing practice surrounding PGHD will 
need to be well differentiated (Foster & Sethares, 2017; Lindroth, Islind, Steineck, & Lundin, 
2018). 
Implications for Future Research 
As new approaches and technologies for collecting PGHD are developed and become 
interconnected, these data are likely to increase in size and complexity. Novel approaches for 
producing meaning and insights from the data are needed. PGHD is unlike “neat” experimental 
data that health sciences researchers typically work with (Hull, 2015; Shaw et al., 2015). Rather, 
it is heterogeneous, originates from a variety of sources, and often in free-text format. This 
presents new challenges for gathering, cleaning, and organizing the data. Current approaches for 
working with “big data” such as machine learning and natural language processing may provide 
solutions, but current applications are limited in their ability manage the heterogeneous nature of 
PGHD (Hsueh et al., 2017; Lai et al., 2017). As described in Chapters Two and Four, patients 
collecting these data, their caregivers, and their healthcare providers, are faced with the task of 
deriving insights to address a specific health concern, such as chronic disease management. This 
process can be time-consuming, confusing, and have myriad legal and social implications that 
have yet to be fully addressed. Therefore, novel methods are needed that translate and display 
PGHD into consumable knowledge that will support actions by patients and providers to 
improve health for individuals, and also for populations of individuals that face common 
problems. 
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In the integrative review in Chapter Two, both patients and providers indicated that they 
prefer visualizations as an approach to efficiently synthesize and act on the PGHD. However 
developing such visualizations can be challenging due to competing requirements. For instance, 
visualizations must balance adequate detail with simplicity. Patients and providers each have 
unique needs from the data, and even within each of these groups, levels of statistical literacy 
and specific questions asked of the data can vary. Moreover, visualizations must support rapid 
interpretation and insights given the potential for data to be overwhelming and time-consuming 
that we documented throughout this dissertation. Pilot testing of different visualizations that 
display complex PGHD has been conducted (Hohenstein et al., 2018; Lindroth, Islind, Steineck, 
& Lundin, 2018), but research on the use of these visualizations within clinical workflows or 
among patients in the community setting has yet to be established. 
Collaborative research on PGHD between data science and other research domains is also 
warranted. Data science and healthcare delivery science intersect at the common aim of reducing 
the cognitive and logistic burden of these data in clinical practice (ONC, January 2018b). 
Additionally, data science work with PGHD carries myriad ethical questions as this space 
evolves. For instance, there exists a tension between the moral obligation to make population-
level insights from PGHD equally accessible to all, and the need to protect personal health 
information (PHI), proprietary algorithms, and other intellectual property (Hsueh et al., 2017; 
Peterson et al., 2013). Moreover, the possibility that PGHD may worsen, rather than ameliorate, 
existing health disparities given evidence that individuals from medically underserved 
backgrounds are less likely to engage in self-monitoring (termed the “digital divide”) must be 
addressed (Dlugasch & Ugarriza, 2014; Lee, 2014; Lobelo et al., 2016). Finally, given close ties 
between a patient’s health data and health behaviors as they collect and use PGHD, data science 
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may benefit from behavior change theories as a means of understanding approaches for 
presenting data in a way that positively influences individual health behaviors (Michie, Yardley, 
West, Patrick, & Greaves, 2017). 
Conclusion 
PGHD holds both promise and pitfalls for healthcare. By offering understanding of the 
patient’s daily experiences through data on lifestyle, mood, symptoms, and physiology, PGHD 
offers a more informative context for providers to make better healthcare decisions. As an 
increasingly valued member of the healthcare team, patients may also better understand their 
own health and, as a result, make better decisions about it. This is especially true for the 150 
million individuals in the U.S. who are living with a chronic condition (Buttorff, 2017), for 
whom daily decisions made outside of clinical settings synergistically impact disease trajectories 
and health outcomes. Nonetheless, questions surrounding technical, logistical, and financial 
aspects of integration of these data into routine care remain unanswered. The complexity and 
volume of PGHD present new challenges for deriving meaning and insights that can be readily 
translated into actionable knowledge. Future research at the intersection of clinical practice, 
policy, and informatics is critically needed to design, develop, and implement solutions that 
address these challenges. Equipped with deep knowledge of the patient experience, nurses are 
uniquely positioned to collaborate across settings, stakeholders, and disciplines to optimize the 
process of PGHD collection and use. Therefore this work can and should involve nurses, but 
practice- and education-based competencies are needed to ensure they are equipped with the 
informatics knowledge necessary to actively participate in these processes. 
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Appendix C: iPhone® Helping Evaluate Atrial Fibrillation Rhythm through Technology 
(iHEART) Trial Surveys providing data for the study in Chapter Three 
 
 









































Canadian Cardiovascular Society 
Severity of Atrial Fibrillation (SAF) Scale 
 
 Step 1 – Symptoms 
 Identify the presence of the following symptoms: 
Palpitation 
Dyspnea 
Dizziness, presyncope, or syncope 
Chest pain 
Weakness or fatigue 
Step 2 – Associat ion 
 Is AF, when present, associated with the above-listed symptoms (A-E)? 
    For example: Ascertain if any of the above symptoms are present 
    during AF and likely caused by AF (as opposed to some other cause). 
Step 3 – Funct iona l i ty  
Determine if the symptoms associated with AF (or the treatment of AF) affect the 
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CCS-SAF Class Definitions 
 
 Class 0 
 Asymptomatic with respect to AF 
 Class 1 
 Symptoms attributable to AF have minimal effect on patient’s general QOL.   
• minimal and/or infrequent symptoms, or  
• single episode of AF without syncope or heart failure 
 Class 2 
 Symptoms attributable to AF have a minor effect on patient’s general QOL.  
• mild awareness of symptoms in patients with persistent/permanent AF, or 
• rare episodes (e.g. less than a few per year) in patients with paroxysmal or 
intermittent AF 
 Class 3 
Symptoms attributable to AF have a moderate effect on patient’s general QOL.  
• moderate awareness of symptoms on most days in patients with 
persistent/permanent AF, or  
• more common episodes (e.g. more than every few months) or more severe 
symptoms, or both, in patients with paroxysmal or intermittent AF 
 Class 4 
Symptoms attributable to AF have a severe effect on patient’s general QOL.  
• very unpleasant symptoms in patients with persistent/paroxysmal AF and/or 
• frequent and highly symptomatic episodes in patients with paroxysmal or 
intermittent AF and/or 
• syncope thought to be due to AF and/or 
• congestive heart failure secondary to AF 
 2
 at Columbia University on January 27, 2012circep.ahajournals.orgDownloaded from 
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iHEART: Baseline Comfort/Experience with Technology Interview Questions 
 
1. Do you currently own a cell phone? YES NO 
2. Do you currently own a smartphone (iPhone, Android, etc.)? YES NO 
2a. Do you use your smartphone to browse the internet? YES NO 
2b. Do you use your smartphone for email? YES NO 
2c. Have you ever downloaded an application on your 
smartphone without any outside assistance? 
YES NO 
3. Do you currently send or receive text messages? YES NO 
3a. Have you ever received and followed a link to a website 
from a text message? 
YES NO 
4. Do you have access to and use a computer/laptop or tablet 
at home? 
YES NO 
4a. Do you have highspeed/wireless internet access? YES NO 
4b. Do you feel comfortable using your computer to browse 
the internet? 
YES NO 
5. Which of the following statements best describes your use and adoption of new 
technologies? 
A. You tend to try new technologies when they are new, before others 
B. You wait a little to see that the new technology has been tested, but adopt them more 
quickly than the average person 
C. You tend to wait until a technology is widely used before trying it 
D. When it comes to adopting new technologies, you tend to wait and are one of the last to 
try 
6. Have you done any of the following to obtain information about your health? (CIRCLE ALL 
THAT APPLY) 
A. Searched for health related information on the internet 
B. Used an electronic organizer or other electronic method to keep track of doctor 
appointments 
C. Used an electronic organizer or other electronic method to keep track of medications 
D. Used technological devices or systems to assist with your healthcare needs 
7. Do you feel you will face challenges using the iHEART 
technologies (smartphone, AliveCor ECG monitoring, text 
messaging) if randomized to the iHEART group? 
YES NO 












     for use until: 10/24/2018
IRB Approval Date: 10/25/2017
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iHEART Patient Satisfaction Survey         
 
The purpose of this survey is to collect information regarding how you felt participating in this study. All 
contents of this survey have been approved by the Columbia University Institutional Review Board (IRB). Your 
responses will be kept confidential and anonymous.  Thank you for your time.   
 
Age:  _______                 Race/Ethnicity:  ___ Asian 
              ___ Pacific Islander 
Gender:                   ___ Black/African American 
                    Male  ____          ___ American Indian/Alaska Native 
              ___ White (Not Hispanic or Latino) 
     Female ____         ___ Hispanic or Latino  
 











1. Ease of using the device:      
     With your fingertips 5 4 3 2 1
On your chest wall  5 4 3 2 1
Overall convenience of the device 5 4 3 2 1
Overall portability of the device 5 4 3 2 1
2. Using AliveCor™ application on iPhone:      
     Layout of the application  5 4 3 2 1
Ease of using the application 5 4 3 2 1
     Collecting the ECG with the application 5 4 3 2 1
     Saving ECG readings using the application 5 4 3 2 1
3. Initial device training with the study team:      
     Explanation of the device and  how it works 5 4 3 2 1
     Showed methods of obtaining an ECG reading with the device 5 4 3 2 1
     Answered your questions in a way you could understand 5 4 3 2 1
4. Follow-up sessions with the study team:      
Explained your ECG results in an understandable way 5 4 3 2 1
     Answered any questions you had about ECG results 5 4 3 2 1
     Overall quality of the follow-up sessions 5 4 3 2 1


















5. Behavioral Altering Motivational (BAM) Messaging:   
Ease of understanding the text messages 5 4 3 2 1
Usefulness of BAM messages in guiding healthy choices 5 4 3 2 1
Usefulness of BAM messages to change your health behavior 5 4 3 2 1
Quantity of text messages received 5 4 3 2 1
6. Overall Satisfaction:   
     Using the device once daily  5 4 3 2 1 
With the device in general  5 4 3 2 1
 
7. What made it EASY to use the AliveCor™ device?  
(PLACE CHECK MARK NEXT TO ALL THAT APPLY)  
_____ Simple device 
_____ Technical support from the study team  
_____ Help from my family/friends 
_____ I’m comfortable with electronics 
_____ Text message reminders from the study team  
_____ I felt good knowing someone was looking at my ECGs daily 
_____ Other (please list) _________________________________________________ 
 
8. What made it DIFFICULT to use the AliveCor™ device? 
(PLACE CHECK MARK NEXT TO ALL THAT APPLY) 
_____ I had to change my regular routine 
_____ I had too many other things on my mind  
_____ New electronic equipment is hard for me to get used to 
_____ I didn’t have anyone help me 
_____ I didn’t have reminders  
_____ Other (please list) _________________________________________________ 
 
9. Did the reminder texts help you to remember to send your ECGs daily? 
_____ Yes 
_____ No 









11. Did you have trouble using your device? If “yes,” how so? 
______________________________________________________________________________ 
______________________________________________________________________________ 
12. Do you feel the device is beneficial?  
______________________________________________________________________________ 
______________________________________________________________________________ 
13. Do you feel more health-conscious after participating in the study using technology? 
______________________________________________________________________________ 
______________________________________________________________________________ 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix E: Illustrative Quotes from Participants in the study in Chapter Four 
1. Ease of Use
1.1 Similarities in Ease of Use 
“I think it’s pretty user-friendly… Three fingers on each side and it saves automatically. 
And for the patients in our research study that are connected to our patient portal, so then 
they don’t even have to do anything further.” –Provider 3 
“It's very handy. It's small. If I'm travelling I can bring it with me and not worry about the 
size and stuff. I remember when they first let me out of the hospital they attached me 
device that measure my heart rate and stuff like that. It was very cumbersome and this is 
just terrific.” –Patient 13 (engaged) 
“It was easy at the beginning, it was easy at the end.” –Patient 1 (unengaged) 
“For the most part, most patients do not document symptoms. Most patients just transmit, 
in our study.” –Research coordinator 1 
1.2 Differences in Responses to Technical Issues 
“Sometimes…if there was a microwave or something going on in the area, it gave a false 
reading… I’ll wait maybe like 30 or 40 seconds or something, maybe clean my fingers, 
and redo the test. And usually it shows up as normal.” –Patient 3 (engaged) 
“I've been working out quite a bit. I can walk in about seven to eight miles a day. I figured 
maybe the EKG isn't reading correctly or it’s just coming up unclassified because [the 
heart rate is] so low. I wasn’t concerned at all.” –Patient 4 (engaged) 
“I didn’t feel safe in my ability to get accurate readings. You’re really talking about sitting 
in your own body and getting scary information…I’m sitting here panicking whether or 
not, I mean, I feel okay but this machine is telling me that I’m not okay.” –Patient 1 
(unengaged) 
1.3 Differences in Healthcare Provider Feedback 
“I did have several false readings…those would at first bother me a little bit but after I 
saw the doctor the first time he said don’t pay attention to those…He took that off the 
table for me to worry about and we spend more time on other things.” –Patient 9 
(engaged) 
“I stopped because it said unclassified and…nothing was happening. And I was going 
insane. What was going on? I wanted feedback.” –Patient 11 (unengaged) 
“It would’ve been nice in the early days to have some sort of positive recognition that, 
you know, “received” or something…Because it was just… Is this really going 
somewhere?” –Patient 2 (unengaged) 
“If you hear from someone who is supposedly a human being to look at it and check it, 
then you’ll feel more confident that it’s probably right.” –Patient 1 (unengaged) 
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“Some of the patients have a misconception about it…someone’s sitting there and 
watching it and then they’ll give feedback right away. But unless somebody opens the 
email and loads it in, and downloads all the different tracings, then there’s no intervention 
right away. So that’s the only downside of it.” –Provider 4 
2. Usefulness of the technology
2.1 Similar Usefulness of Identifying Rhythm 
“With this I get affirmation each day that there’s normal heartbeat, no abnormalities” – 
Patient 2 (unengaged)  
“My life would be much, much different without it, just because of the stress that not 
knowing causes…that lack of assurance that I'm in rhythm in itself causes stress. So, 
having that AliveCor device…it just reassures me.” –Patient 13 (engaged) 
 “For the first time it allows patients to record their own EKG with a very high quality 
device that they can keep with them indefinitely. So that is a major shift in the way we’ve 
been able to monitor patient’s EKG’s for arrhythmia.” –Provider 6 
2.2 Differences in Insights and Perceived Value of the Data 
“If I went for a walk or something, then again when I got home from the walk I would do 
it. Just to find out, for my own information, if there was any kind of effect from any 
outside activities.” –Patient 3 (engaged) 
“Sometimes I'll forget to take the medication but I never forget [Alivecor]…I know why. 
Because I value the feedback that it gives me tremendously.” –Patient 13 (engaged) 
“I guess if I went into A fib and believed the readings, it would definitely help me to 
contact my cardiologist and discuss our options. So to that end it would be useful, but 
when you think something’s not working it’s just worse.” –Patient 1 (unengaged) 
“You guys know if it’s a weird reading, but I don’t know that it’s a weird reading…I 
mean, I feel okay but this machine is telling me that I’m not okay.” –Patient 1 
(unengaged) 
“AliveCor creates too many false positive readings where it says atrial fibrillation or 
possible atrial fibrillation. It seems like it needs more work because then it creates when 
it’s false positive it’s creates anxiety and unnecessary phone calls and emails just because 
the computer said it was atrial fibrillation.” – Provider 6 
“You just told me something I never noticed. That I can go back and see it all. I didn’t 
know that. I never looked at it.” –Patient 10 (unengaged) 
“I’m blissfully unaware of other stuff that I should want to know… I don’t know if there’s 
any other data that would be meaningful to me.” –Patient 2 (unengaged) 
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2.3 Differences in Healthcare Provider Feedback 
“AliveCor was an improved process for both me and for the physician because they had 
something that they could read…that was not a patient testimonial.” –Patient 9 (engaged) 
“It’s potentially a long-term commitment… to stay engaged as we can to try to sort out 
why they’re having this rhythm problem and identify any triggers. Often there are not 
identifiable triggers. Sometimes there are. But again, most of the patients are willing to do 
that.” –Provider 5  
“So, I was using it for quite a while…When I stopped, and I think part of it was getting 
the message unclassified kind of made wonder what the utility of this thing was. It was 
unclassified. What does that mean? And nobody guided me… I originally joined this 
study because I wanted to know what was going on.” –Patient 10 (unengaged)  
“I, in fact, encourage them to not check it as often… We have a treatment plan, there’s 
really not much else that we can glean from the data, and so for them to perseverate on it 
– it just doesn’t serve any purpose besides potentially causing more anxiety about it.” –
Provider 5 
3. Facilitating Conditions
3.1 AF Severity: Long AF Histories but Varying Proactive Behaviors 
“The first time I didn’t take it seriously and then by the third I said enough is enough. 
Like I said I switched my diet. I started working out and I'm hoping not to have that again 
because I really don’t want to have an ablation.” –Patient 4 (engaged) 
“I tried to use it every morning right after the ablation and pretty much through the first 
six months, I was probably pretty religious about it…As my rhythm returned to just a 
bunch of more normal kind of activity it became something I checked less.” –Patient 9 
(engaged) 
“After I had the ablation and it went back that quick, you know, a few hours later, that 
was, yeah, that was a disappointment.” –Patient 2 (unengaged) 
“I’m no longer in [AF], at least, each time that I’ve been checked since the 
[intervention]… I go in about every six weeks, just to be checked.” –Patient 1 
(unengaged) 
“It’s not that they lost interest. The issue is that for the clinical part… treatment is 
achieved and the patients are doing well…They’re not less engaged, they’re appropriately 
using it.” –Provider 1 
 “These [engaged] people they know if they’re out of rhythm, because that’s the only time 
they’re using it. If they’re less using it, they’re doing great, the ablation worked. The only 
issue will be the asymptomatic one. Those are the ones, they’re going to miss it.” –
Provider 2 
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3.2 AF Knowledge: Differences in Uncovering Self-knowledge 
“[This] patient population happens to be in general very sophisticated and educated so I 
can’t say this is generalizable to all patient populations. Almost all the patients have smart 
phones and so that says something.” –Provider 6 
“I think that what changed was my sense of how this problem was affecting my day to 
day life…the one doctor that I had since I was using [AliveCor] was pretty aware of what 
was going on with my body as a result of it. I don't think that the AliveCor affected his 
knowledge of what was going on with me. I think it was my own understanding of what 
was going on.” –Patient 13 (engaged) 
“[My doctor] had told me that relatively speaking [caffeine is] the least effective trigger 
for me. He said alcohol is the worst and it definitely is, there's no question.” –Provider 7 
(unengaged) 
3.3 AF Symptoms: Driving Use for Unengaged Patients 
“It’s like…Atrial Fibrillation hiding out on you” –Patient 10 (unengaged)  
“Without the device, no other way to do it… it’s not I can feel [my symptoms] in my 
body necessarily, but I can certainly feel them in my energy level, if I’m in AFib or not. 
So the Kardia device sort of corroborates my AFib symptoms because I’m thinking I’m 
having it because of my energy level being up or down.” –Patient 6 (engaged) 
“When I feel fine, I’m not gonna use it.” – Patient 5 (unengaged)  
“I probably use it too much because every time I have chest pain, I just pull it out. And 
after a while, I just stop that…Because I can’t be doing it all the time.” –Patient 5 
(unengaged) 
“Well, I guess it’s how you feel…I’ve been on a six or eight week cycle of seeing my 
cardiologist. And I’m more comfortable with that.” –Patient 1 (unengaged) 
“Most patients… are not always out of rhythm when they do document symptoms, and 
not always an A fib when they do document symptoms… they might feel light-headed or 
something at that particular time. So a lot of the time, what they perceive to be something 
is not always the case.” –Research Coordinator 1 
“[My symptoms are] not at all predictive anymore, it seems.”  
4. Moderators: Age, Gender, and Experience with Technology 
4.1 Age 
“I have a mother who has AFib, she's 85, she's not using any technology because she's 85. 
It took me three years to convince her to get a laptop. So she can read email and still 
doesn't know how to open attachments so she is never going to use something like the 
device.” –Patient 7 (unengaged) 
“I’ve been surprised by how easily patients even in their 60’s, 70’s and 80’s have adopted 
using this. Not a lot of pushback. Patients find this empowering and patients like having 
this.” –Provider 6  
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4.2 Experience with Technology 
“I know my way around the computers” – Patient 4 (engaged)  
“I picked it up very easily. It was simple. And I’m not very good—I can’t even program a 
remote control.” –Patient 5 (unengaged) 
“I found a free app that’s called heart rate something… this was before Kardia. It takes 
the pulse through your thumb… I could see where I was heart rate wise.” –Patient 8 
(engaged) 
“I did a diary for my cardiologist. It was more about how much medication I should take 
and how I was feeling within the first couple of hours after I take it.” –Patient 1 
(unengaged) 
 “It’s not always the most cognitive or the most savvy individual. Our first patient in the 
trial would comply with sending his transmissions, and he wasn’t the most tech savvy 
person. But his enthusiasm for his care was there.” –Research Coordinator 1 
5. New Factors 
5.1 Personality traits and behavioral tendencies  
“I’d like to live a long healthy life and being 50 years old, it’s time to make a change. I'm 
hoping…I can continue to have a quality of life as I grow older.” –Patient 4 (engaged)  
“I would want to know if there’s something wrong. I’m worried about not doing OK and 
not knowing about it.” –Patient 11 (unengaged) 
“There are patients who, psychologically, just want to reassure themselves…once they see 
something unusual from the baseline…they panic. Once they panic, or they just see 
something different, they call right away.” –Provider 1 
5.2 Relationship with Healthcare Provider 
“With the AliveCor™ device at Columbia, I feel like I am, you know, 99% in tune with 
them, or they with me, because it just gives them such important information.” –Patient 6 
(engaged) 
“Oftentimes the physician’s assistant will get it and she will refer to it and talk it over 
with the doctor, so he always knows what’s going on too, and then by email, she’ll write 
me back and say, you know, I think that you should continue with a certain medication 
and maybe stop this one, et cetera, but keep sending this to us because they’re very 
helpful.” –Patient 6 (engaged) 
“There should be some way to use this equipment to my advantage beyond supporting the 
efforts of someone like Dr. X or collecting data for medical research…I’m happy to share 
my information but it seemed like a one-way street where you guys were just taking my 
information and I’m out there on my own. Without a contact in the event of something 
like the machine not working correctly.” –Patient 1 (unengaged) 
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“Anybody in the medical system needs an advocate, and you’ve got to be an advocate 
person foremost yourself…we all know that there’s an awful lot of stuff that we can do to 
impact that care and impact our general well-being and so forth…we’ve got to be 
involved.” –Patient 2 (unengaged) 
5.3 Creating Supportive Environments 
“It’s just part of my daily ritual…first thing I do when I wake up, it’s right by my 
nightstand. Just pick it up, check my messages of course, see my EKG 30 seconds and in 
the shower and get the day started.” –Patient 4 (engaged) 
“Wallet, dollar bills, glucose tablets. Everything goes in my pockets, along with that 
[AliveCor] device, so I carry with me all the time.” –Patient 7 (unengaged) 
“If I've missed the night I know to do it early in the morning and then just do twice the 
next day. It’s rare…If I'm traveling I’ll take it with me.” –Patient 8 (engaged) 
“Remembering was difficult but my wife was very helpful in the evenings and in the 
mornings.” – Patient 13 (engaged)  
“I’m still using it right now. And I’m planning to sign up to use it after the trial 
period…it’s a big help for me! At least I would know, and then if I did have a problem, I 
could go into the hospital and get it attended to before it turns into some sort of dangerous 
issue.” –Patient 3 (engaged). 
“On weekends I didn't do it…from the beginning I wasn't doing it every day. I guess, I 
just forgot it. I don’t take it to work.” –Patient 11 (unengaged). 
“I find that most of my patients after the study is over stop doing it every day, or they stop 
doing it at all. Other people lose the device or they don’t replace the battery.” –Provider 6 
